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CHAPTER 1. INTRODUCTION 
 
This dissertation consists of eight chapters. Chapter 1 Introduction will delineate 
the goals of the research. Chapter 2 Background reviews the literature with 
respect to stem cell transplantation in ischemic heart disease and myocardial 
bioenergetics in animal models of heart disease. The specific projects are 
addressed in Chapter 3,4,5 and 6. Chapter 7 Conclusion summarizes the results 
of the thesis research.  
 
The specific aims of the current thesis are as follows: 
• To examine the safety and effects of stem cell transplantation through a 
transcoronary injection in a clinically relevant ischemia/reperfusion 
porcine model using a catheter based approach. The functional and 
bioenergetic effects of stem cell transplantation and the mechanisms 
underlying the beneficial effects will be examined short term at 4 weeks. 
(Chapter 3) 
• To examine the long terms functional and bioenergetic effects of stem cell 
transplantation in a porcine model of post-infarction left ventricular 
remodeling. The engraftment of cells will be examined long term at 4 
months. Differential expression of genes will be studied to explore 
mechanisms underlying the beneficial effects of stem cells. (Chapter 4) 
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• To create a model of chronic hibernating myocardium in mini-pigs and 
examine the long term myocardial bioenergetics in this model.         
(Chapter 5) 
• To examine the effects of adenosine and K+ATP channel blockade on 
myocardial energetics in the failing heart. (Chapter 6) 
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CHAPTER 2. BACKGROUND 
 
2.1. Stem cell transplantation in ischemic heart disease 
 
Although coronary interventions and medical therapy improve post-infarction 
cardiac function in patients with coronary artery disease, approximately 45% 
progress to endstage heart failure [1]. Cardiac transplantation is the only 
definitive therapy for replacing the lost muscle, but it is limited by the inadequate 
supply of donor hearts. A potential therapy for limiting post-infarction left 
ventricular (LV) remodeling and the development of CHF is the replacement of 
infarcted myocardium with new myocardium generated from transplanted stem 
cells. 
 
Recent studies have provided evidence to support the notion that cardiomyocyte 
regeneration may occur during physiological and pathological states in the adult 
heart;  these data highlight the possibilities that myocardial regeneration may 
occur via cardiomyocyte proliferation or proliferation and differentiation of 
putative cardiac stem cells [2]. A number of cell types have been used for cardiac 
repair, including skeletal myoblasts, bone marrow derived cells, mesenchymal 
stem cells (MSCs), endothelial progenitor cells (EPCs), umbilical cord blood stem 
cells, cardiac stem cells (CSCs), and embryonic stem cells (ESCs). 
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The bone marrow (BM) contains many adult stem cells, which have been used to 
treat hematological disorders for decades. It has recently been shown that bone 
marrow derived stems can traverse cell lineage boundaries and upon appropriate 
stimulation transdifferentiate into hepatocytes, endothelial cells, skeletal muscle 
and neurons [3-5]. The ability of bone marrow derived cells to differentiate into 
cardiomyocytes is controversial. Bittner et al. were the first to suggest that 
cardiac muscle cells may be derived from BM cells [6]. Goodel et al. 
demonstrated that following transplantation of murine BM Side population (SP) 
cells (c-kit+, Sca-1+, CD34-/low), donor derived cells with cardiomyocyte 
morphology as well as smooth muscle and endothelial cells were found in the 
heart following left anterior descending (LAD) coronary artery ligation [7]. Orlic et 
al. [8] showed that transplantation of GFP-labeled Lin-c-kit+ cells [presumably 
containing both hematopoietic stem cells (HSC) and mesenchymal stem cells] 
into the ventricular wall after LAD coronary artery ligation resulted in improved 
function of the ventricle and they detected a large number of GFP+ cells that 
coexpressed myocardial proteins in the myocardium. In contrast to these 
findings, other laboratories using genetic mouse models to label cell populations 
(and their derivatives) showed that lineage negative, c-kit positive cells did not 
differentiate into cardiomyocytes [9-10]. However, more recently Anversa and 
colleagues have shown using similar genetic techniques, that c-kit+ bone marrow 
cells can engraft in the injured myocardium and differentiate into cells of the 
cardiogenic lineage, forming functionally competent cardiomyocytes and vascular 
structures [11]. 
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In the late 1980s and in the 1990s, Caplan’s laboratory identified a subset of cells 
within the bone marrow which gave rise to osteoblasts and adipocytes and 
termed them Mesenchymal Stem Cells (MSCs) [12]. MSCs are present in many 
different organs of the body including muscle, skin, adipose tissue and bone 
marrow. They can be isolated from the bone marrow by a simple process 
involving Ficoll centrifugation and adhering-cell culture in serum-containing 
medium. In the early studies, MSCs could be expanded for 4 to 20 population 
doublings only [13] with preservation of the karyotype, telomerase activity and 
telomere length [14-15]. Phenotypically, these cells are negative for CD31, CD34 
and CD 45, unlike hematopoietic progenitors from bone marrow, and are positive 
for CD29, CD44, CD71, CD90, CD105, CD106, CD120a, CD124, SH2, SH3 and 
SH4 [16-18]. In the bone marrow, only 0.001-0.01% of the initial unfractionated 
bone marrow mononuclear cell (BMMNC) population consists of MSCs [13, 16]. 
However, in a number of rodent studies, the adherent fibroblastic cells obtained 
from the unfractionated mononuclear class of the bone marrow are termed 
mesenchymal stem cells [19-20].  
 
MSCs have been reported to have the potential to differentiate into any tissue of 
mesenchymal origin [12]. MSCs derived from rodent marrow aspiration have 
been shown to differentiate into cardiomyocyte like cells in the presence of 5-
azacytidine [21-22]. The morphology of the cells changes from spindle shaped to 
ball shaped and finally rod shaped form. Thereafter, these cells fuse together to 
form a syncitium which resembles a myotube [23]. These cells exhibit markers of 
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fetal cardiomyocytes [22]. Specific transcription factors of the myocyte and 
cardiac lineage including GATA4, Nkx2.5 and HAND 1/2 can be detected [21]. 
There are differences (as compared to native cardiomyocytes) in cardiomyocytes 
derived from MSCs. First, the ß-isoform of cardiac myosin heavy chain is more 
abundant than the α-isoform in these cells. Second, myosin light chain 2v is 
present. Third, MEF2A and MEF2D replace MEF2C isoforms from early to late 
passage.  It is reported that these cells beat spontaneously and synchronously, 
which is most likely due to the formation of intercalated discs, as has been shown 
when they are co-cultured with neonatal myocytes [24]. They express competent 
α- and ß-adrenergic and muscarinic receptors as indicated by an increased rate 
of contraction in response to isoproterenol and a decreased rate of contraction 
induced by ß-adrenergic blockers [25].  Other studies suggest that bone marrow 
stem cells can not differentiate to the cardiac myocytes (29,30).  Whether MSCs 
can differentiate into functional cells of 3 lineages requires further investigation.    
 
MSCs have features that make them attractive candidates for cell 
transplantation. As they are easily accessible and expandable, MSCs could 
potentially become an “off the shelf’ allogeneic product, which would be more 
cost effective, easier to administer, allow a greater number of cells to be 
transplanted and permit transplantation at the time of urgent interventions to 
relieve ischemia and injury such as percutaneous or surgical revascularization 
procedures. Importantly, these cells appear to be hypoimmunogenic [26-28]. 
These cells lack MHC-II and B-7 costimulatory molecule expression and thus 
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limit T-cell responses [29-30]. They can also directly inhibit inflammatory 
responses via paracrine mechanisms including production of transforming growth 
factor beta1 and hepatocyte growth factor [31-32]. All the above properties make 
them attractive candidates for cell transplantation. 
 
MSC transplantation was tested in a study in which isogenic adult rats were used 
as donors and recipients to simulate autologous transplantation clinically. MSC 
intracoronary delivery in these rat hearts following myocardial infarction showed 
mileu dependent differentiation of these cells; fibroblastic phenotype within the 
scar and cardiomyocyte phenotype outside the infarction area [33]. However, 
direct intramyocardial injection of autologous MSC into the scar resulted in the 
differentiation into cardiac like muscle cells within the scar tissue, increased 
angiogenesis and improved myocardial function [34]. The delivery of MSCs via 
direct left ventricular cavity infusion in a rat myocardial infarction model resulted 
in preferential migration and colonization of the cells in the ischemic myocardium 
at 1 week [35]. MSCs also resulted in increased vascularity and improved cardiac 
function 2 months following delivery in a canine model of chronic ischemic 
disease [36]. However, Kloner’s laboratory using a rat model of postinfarction LV 
remodeling found that the beneficial effect on left ventricular function was short 
term and was absent after 6 months [37].  
 
MSC transplantation has led to functional improvement in large animal models of 
myocardial infarction. Direct intramyocardial injection of 5-azacytadine treated 
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autologous MSCs was performed 4 weeks after MI in a swine model. These cells 
formed islands of cardiac like tissue, induced angiogenesis, prevented thinning 
and dilatation of the infarct region, and improved regional and global contractile 
function [38].  
 
Bone Marrow Cells (BMCs) have also received intense interest for cell therapy 
use for patients with cardiovascular disease. The Transplantation of Progenitor 
Cells and Regeneration Enhancement in Acute Myocardial infarction 
(TOPCARE-AMI) trial revealed significant improvement in LV ejection fraction as 
well as significantly enhanced myocardial viability and regional wall motion in the 
infarct area following transplantation of BMMNCs or blood derived progenitor 
cells [39-40]. The Bone marrow transfer to enhance ST-elevation infarct 
regeneration (BOOST) study [41] also showed an increase in LV ejection fraction 
at 6 months with cell transplantation, but surprisingly there was no difference 
between the treated and placebo groups at 18 months. Reinfusion of Enriched 
Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-
AMI) trial [42] randomized 204 patients with acute MI to receive an intracoronary 
infusion of progenitor cells derived from bone marrow or placebo medium into the 
infarct artery 3 to 7 days after successful reperfusion therapy. The absolute 
increase in LVEF was significantly greater (2.5%) in the BMC group than in the 
placebo group at 4 months. However, other trials (ASTAMI- Autologous Stem 
Cell Transplantation in Acute Myocardial Infarction and STEMI- ST-elevation 
Acute Myocardial Infarction) [43],[44] have shown negative results with no 
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improvement in ejection fraction with cell transplantation Differences in cell 
preparation [45] and numbers have been proposed as possible causes for these 
conflicting results. Bone Marrow Cells have also been used in chronic heart 
failure setting; In the Transplantation of Progenitor Cells and Recovery of LV 
Function in Patients with Chronic Ischemic Heart Disease (TOPCARE-CHD) trial 
[46], 75 patients with stable ischemic heart disease who had had a myocardial 
infarction at least 3 months previously were assigned to receive either no cell 
infusion or infusion of circulating progenitor cells or BMC into the patent coronary 
artery supplying the most dyskinetic left ventricular area. The transplantation of 
BMC was associated with a moderate (2.9 percentage points), but significant 
improvement in left ventricular function 3 months post-transplantation. 
 
MSC transplantation has been used in patients with acute myocardial infarction 
18 days after primary percutaneous intervention and resulted in significant 
improvement in LVEF up to 6 months [47-48]. This was associated with a 
significant reduction in the size of the perfusion defect measured by positron 
emission tomography at 3 months [47-48]. More recently, it has been 
demonstrated in a randomized double blind placebo controlled trial that 
intravenous delivery of allogenic human MSCs leads to improved ventricular 
function after myocardial infarction [49]. The degree of response to IV therapy 
occurs early after MI and compared favorably with previous studies using 
intacoronary infusions of bone marrow [49]. 
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Thus, it seems that a large amount of preclinical data supports the hypothesis 
that stem cell treatment has potential in improving left ventricular function post 
myocardial infarction, but the clinical data is not as convincing. The main theme 
of the current thesis is that the clinical data so far has raised many questions 
which require definitive answers. Specifically, it needs to be established whether 
stem cell transplantation leads to functional improvement if delivered 
intracoronary through a catheter versus an intramyocardial injection. Secondly, it 
has to be determined if stem cell treatment leads to long term functional and 
bioenergetic improvement. Moreover, stem cell engraftment and differentiation 
many months after transplantation needs to be investigated. Thirdly, paracrine 
mechanisms underlying the beneficial effects of stem cell transplantation need 
further exploration. 
 
These questions can only be answered by performing experiments on large 
animal models of myocardial infarction. Our laboratory has a well established 
model of post infarction left ventricular remodeling. In this model, acute coronary 
occlusion is followed by remarkable remodeling of the non-infarcted myocardium 
with LV chamber dilation, reduced systolic performance, increased systolic and 
diastolic wall stresses and significant bioenergetics abnormalities. All of these 
alterations are correlated with the size of the initiating infarct. The severity of the 
abnormalities varies from compensated ventricular dysfunction to frank heart 
failure, which develops in 20-30% of animals. The feasibility of performing 
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detailed in vivo physiological and biochemical studies makes this an excellent 
model for detailed studies of hearts with post-infarction LV remodeling.  
 
 
2.2. Myocardial Bioenergetics 
 
Cardiac energy metabolism has three components. The first is substrate 
utilization which involves the cellular uptake of substrates (mainly fatty acids and 
glucose) and their breakdown by beta-oxidation and glycolysis resulting in the 
formation of acetyl coenzyme A (CoA), which is fed into the Krebs cycle and 
produces NADH and carbon dioxide (CO2). The second component is oxidative 
phosphorylation which involves transfer of electrons from NADH to oxygen 
through the mitochondrial respiratory chain that creates a proton electrochemical 
gradient across the inner mitochondrial membrane subsequently driving the F1-
F0 ATP synthase to produce ATP by phosphorylating ADP. The third component 
is ATP transfer and utilization that involves the creatine kinase shuttle. The 
principal method for studying in vivo myocardial energy metabolism is through 
NMR spectroscopy. Our laboratory has specialized in performing in vivo NMR 
spectroscopy in large animals to study abnormalities in high energy phosphate 
metabolism, oxidative phosphorylation, creatine kinase kinetics and flux, and 
substrate utilization. 
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Our laboratory has created a porcine model of postinfarction remodeling to study 
myocardial energetics [50]. Proximal circumflex artery was occluded in 18 young 
pigs and 12 went on to develop left ventricular remodeling (LVR) after about 50 
days while 6 developed LVR and CHF within 20 days. The mean scar surface 
area expressed as a ratio of the total LV surface area was 0.16±0.02 and 
0.31±0.03 in the LVR group and LVR+CHF group respectively. This resulted in 
ventricular hypertrophy in the LVR group as compared to control animals while 
the LVR+CHF group had the most hypertrophy (LV weight/Body weight was 
3.03±0.12 vs. 3.65±0.25 vs. 4.99±0.42). The infarct caused a decrease in 
ejection fraction to about 35% and 27% in the LVR and LVR+CHF groups, 
respectively. LV end-systolic volume increased significantly in both groups of 
animals with remodeling and was significantly higher in LVR+CHF hearts than in 
LVR hearts. Both LV diastolic wall stresses and mean LV systolic wall stresses 
were significantly increased in hearts with LVR and were further increased in 
LVR+CHF hearts. The bioenergetic abnormalities were characterized by a lower 
ATP, CP, creatine and PCr/ATP ratio in the LVR hearts and the LVR+CHF hearts 
had an even lower PCr/ATP ratio. The myocardial calculated free ADP levels 
were significantly increased only in CHF hearts. The increase in myocardial free 
ADP was associated with reductions in mitochondrial F0F1-ATPase protein 
expression[51]. These HEP levels did not improve with increasing blood flow with 
adenosine although the subendocardial flow reserve was impaired in CHF 
animals. A subsequent study revealed that the CK-M and CK-mito protein levels 
were decreased in LVR animals while the CK-B levels were increased [52]. 
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However, the total CK activity did not change significantly in the LVR group [52]. 
These changes may partially contribute to the altered HEP metabolism in hearts 
with postinfarction remodeling. Subsequently, it has been shown that the CK flux 
rates are decreased in hearts with postinfarction remodeling but this change 
does not seem to limit their response to dobutamine [53]. However, the animals 
that develop CHF have further decreased high energy phosphates and CK flux 
rate and these changes may contribute to their decreased response to 
dobutamine [53]. It is also known that the decrease of PCr/ATP in LVR animals 
during dobutamine infusion is not the result of insufficient myocardial oxygen 
availability [54]. Furthermore, in CHF hearts, the low basal PCr/ATP and the 
attenuated response to dobutamine occurred in the absence of myocardial 
hypoxia, indicating that the HEP and contractile abnormalities were not the result 
of insufficient oxygen availability [54]. There is also a loss of total adenine 
nucleotide pool in hearts with postinfarction remodeling as shown by 
accumulation of interstitial purine metabolites found in a rat model of 
postinfarction remodeling [55]. The alterations in myocardial HEP and mtATPase 
have been shown to be substantially more severe in the peri-infarct region than in 
the remote zone of hearts with compensated postinfarction LV remodeling [56]. 
These abnormalities mirror the contractile dysfunction of the border zone 
myocardium and may play a role in the eventual transition to heart failure. The 
bioenergetic and contractile abnormalities of the BZ, which are triggered by 
elevated regional wall stress, may extend laterally and eventually involve the 
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entire LV, thereby leading to global LV dysfunction and the development of 
CHF[57]. 
 
Substrate utilization in post-infarction LV hypertrophy also exhibits shifts in fatty 
acid and glucose metabolism. In a post-infarction rat model, glucose oxidation 
was increased by 84% while there was no change in palmitate oxidation 8 weeks 
after MI [58]. The pattern of gene expression regulating substrate utilization could 
change as LV remodeling progresses to heart failure, so the same group 
followed these animals for 20 weeks [59]. At 8 weeks, when left ventricular 
hypertrophy was present without signs of heart failure, myocardial mRNA 
expression of glucose transporters (GLUT-1 and GLUT-4) was not altered, 
whereas mRNA expression of medium-chain acyl-CoA dehydrogenase (MCAD) 
was significantly reduced in the peri-infarction region. In hearts exhibiting heart 
failure 20 weeks after infarct-induction there was a change of both mRNA and 
protein content of GLUT-1 and MCAD [59]. 
 
Congestive Heart Failure (CHF) is associated with a decrease in coronary blood 
flow (CBF) that is matched to a decrease in myocardial oxygen consumption 
(MVO2) suggesting a down-regulation of energy utilization [60].  Our laboratory 
has previously shown that in normal animals ATP sensitive Potassium (KATP) 
channel blockade inhibits the decrease in myocardial energy demands in 
response to hypoperfusion [61]. KATP channel blockade with intracoronary 
glibenclamide resulted in a decrease in CBF and MVO2 without a change in the 
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relationship between CBF and MVO2 in CHF animals [62]. The effect of KATP 
channel blockade on myocardial energetic in CHF animals remains to be 
investigated. 
 
In clinical practice, hibernating myocardium refers to areas of regional 
dysfunction, decreased blood flow and absence of scar in patients with coronary 
artery disease which are thought to recover after revascularization [63-65]. In 
animal models, chronic hibernating myocardium can be created by constriction of 
a proximal coronary artery that leads to progressive reduction in myocardial 
blood flow and regional dysfunction [66-76]. As opposed to acute ischemia and 
congestive heart failure, animals with chronic hibernation at short term follow-up 
had well preserved myocardial energetic despite a reduction in myocardial blood 
flow and regional function [75]. However, myocardial energetic have not been 
characterized in a long term follow-up of chronic hibernating myocardium. 
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Using a swine model of postinfarction LV remodeling, this study investigated 
marrow derived multi potent progenitor cell (MPC) transplantation into hearts with 
acute myocardial infarction (AMI) via a novel trans-arterial catheter. The left 
anterior descending artery was balloon occluded after percutaneous transluminal 
angiography to generate AMI (60 minute no-flow ischemia). The trans-arterial 
catheter was then placed in the same coronary artery and either 50 million MPCs 
(Cell, n=6) or saline (Control, n=6) were injected into the border zone 
myocardium (BZ). LV function was assessed by MRI at pre-AMI, week 1 and  
week 4 post AMI, whereas myocardial energy metabolism was assessed by 31P-
MR spectroscopy at week 4.  One week after AMI, the ejection fraction (EF) was 
significantly reduced in both groups from a baseline of ~ 50% to 31.3±3.9 (Cell) 
and 33.3±3.1 (Control). However, at week 4, the Cell group had a significant 
recovery in EF. The functional improvements were accompanied by a significant 
improvement in myocardial bioenergetics. Histological data demonstrated a 
0.55% cell engraftment rate 4 weeks after MPC transplantation. Only 2% of 
engrafted cells were co-staining positive for cardiogenic markers. Vascular 
density in the BZ was increased in the Cell group. Conditioned medium from 
cultured MPCs contained a high level of VEGF which was increased in response 
to hypoxia. MPCs cocultured with cardiomyocytes inhibited cardiomyocyte 
mitochondrial membrane potential change and cytochrome C release induced by 
TNFα. Thus, a paracrine effect may contribute significantly to the observed 
therapeutic effects of MPC transplantation. 
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INTRODUCTION 
 
Stem cell transplantation has emerged as a novel therapeutic strategy for 
limiting post-infarction left ventricular (LV) remodeling and the consequent 
development of congestive heart failure (CHF) in both animal [77-80] and clinical 
[39, 41-42, 44, 46] studies. Using a swine model of post myocardial infarction 
(MI) LV remodeling, we recently reported that transplantation of bone marrow 
derived multipotent progenitor cells (MPCs) resulted in a significant improvement 
of cardiac function and correction of abnormal energy metabolism [77]. However, 
the mechanisms underlying these beneficial effects are not well defined. We and 
others have demonstrated a very low engraftment rate and even lower 
cardiomyocyte differentiation rate a few weeks after bone marrow stem cell 
transplantation [77, 81]. Therefore, the direct contribution of regenerated 
myocytes to the improved cardiac contractile function appears less likely. Dzau’s 
group has shown a significant protection of stressed cardiomyocytes from 
apoptosis and consequent reduction in infarct size by injection of concentrated 
cell culture medium that was obtained from bone marrow derived mesenchymal 
stem cells (MSCs) with overexpression of Akt, or by injection of MSCs 
themselves into the myocardium at the time of acute myocardial infarction [81-
83].  More recently they demonstrated that the frizzled related protein 2 (Sfrp2) is 
the key paracrine factor secreted by Akt-modified MSCs that mediates 
myocardial survival and repair [84]. Using a swine model of concentric left 
ventricular hypertrophy (LVH), we have demonstrated that transplantation of 
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vascular endothelial growth factor (VEGF) overexpressing MSCs (VEGF-MSCs) 
at the time of ascending aortic banding markedly attenuated the development of 
LVH and resulted in the preservation of LV contractile performance and 
bioenergetic characteristics [85], supporting the notion that the beneficial effects 
after bone marrow stem cell transplantation are mediated through a paracrine 
mechanism by secretion of  trophic factors from stem cells that exert a protective 
effect.  
 
        Many different approaches have been used to deliver stem cells into the 
heart including direct intramyocardial, intravenous, intracoronary and retrograde 
coronary venous routes [86]. Intracoronary infusion of stem cells at the time of 
angiography seems the most practical approach clinically.  However, its efficacy 
and safety remain an issue. Using a canine model, it was reported that coronary 
artery infusion of stem cells resulted in blockage of small vessels, which in turn 
caused discrete micro-myocardial necrosis [87].  The Micro-Syringe Infusion 
Catheter (From Mercator MedSystems, CA) used in the present study has the 
unique feature of a micro-needle that penetrates the coronary artery wall and 
allows the user to inject the stem cells directly into the myocardium.  
 
The present study has a two-fold hypothesis. Firstly, we hypothesize that 
MPC delivery via the Micro-Syringe Infusion Catheter would be safe and effective 
in a clinically relevant porcine model of myocardial ischemia reperfusion. 
Secondly, we hypothesize that “a trophic effect” plays an important role in 
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mediating the myocardial structural changes that lead to the beneficial effects of 
cellular therapy.  Namely, the engrafted cells release cytokines that result in 
enhanced angiogenesis, maintenance of mitochondrial integrity, and inhibition of 
apoptosis of ischemia threatened and overstretched myocytes in the border zone 
myocardium (BZ) adjacent to the myocardial infarct. These structural changes 
are accompanied by the improvement of BZ myocardial contractile performance, 
which in turn, results in ameliorating the LV wall stress and myocardial 
bioenergetics.   
 
METHODS 
 
All experiments were performed in accordance with the animal use 
guidelines of the University of Minnesota, and the experimental protocol was 
approved by the University of Minnesota Institutional Animal Care and Use 
Committee (IACUC). The investigation conformed to the “Guide for the care and 
use of laboratory animals” published by the National Institutes of Health (NIH 
publication No 85-23, revised 1985). 
 
Cell Culture  MPCs were provided by Athysis  Inc., which were derived 
from one of the male swine multipotent adult progenitor cell (MAPC) lines 
generated at the University of Minnesota [88]. MPCs isolation, expansion and 
differentiation were performed as described previously [77]. 
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Bone marrow derived Multipotent Progenitor Cells (MPCs) were provided from 
Athysis Inc. The MPCs were expanded from one of the established swMAPC 
(swine multipotent adult progenitor cell) lines generated in the laboratories of Drs. 
Verfaille and Zhang [88]. MPCs were transduced with a Lac-Z Retrovirus (RV) 
supernatant (Lac-Z RV supernatants were generated by co-transfection of pVSV-
G retroviral vector (BD Biosciences) and pCL-MFG-LacZ RV packaging vector 
(Imgenex) using the calcium phosphate method (BD Bioscience, K2051-1) in GP-
293 cell line (BD Bioscience). Following transduction with a Lac-Z retrovirus at 
Athersys Inc., re-evaluation of the cells indicated that the level of Oct3a was 
significantly lower than in the parent population, and that the cells expressed 
CD44 and MHC-class I.  Cells were maintained for extensive population 
doublings (>100) following gene marking and large scale expansion (data not 
shown), and were cytogenetically normal.  Cells were assayed for in vitro 
differentiation response by quantitative PCR, with induction of lineage specific 
markers compared to non differentiated controls. The robustness of 
differentiation to hepatocyte and neuroectoderm-like cells was reduced in Lac-Z 
transduced cells, which expressed low Oct3a transcript levels compared with the 
parent cells that expressed high levels of Oct3a.  These MPCs have previously 
been shown to maintain multi-potent differentiation potentials [77]. 
 
The transduced swine cells were expanded using methods developed for clinical 
scale production of human MultistemTM.  The detailed cell culture methods have 
been previously described [77]. Briefly, cells were cultured in 60% DMEM-LG / 
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40% MCDB-201 supplemented with 1x ITS, 0.5x LA-BSA, 0.1mM L-ascorbic acid 
2-phosphate, 100U penicillin and 1,000U streptomycin, 50 nM dexamethasone 
and 2% pre-screened FBS with 10 ng/ml each human PDGF-BB and human 
EGF and passaged every 2 to 3 days through removal of the growth media and 
addition of 5 ml 0.25% trypsin per T150 flask.  
 
MPCs were harvested, centrifuged and resuspended at 10 million cells / 1 ml 
cryo preservation solution that consists of 70% growth media, 20% FBS, and 
10% DMSO in 1 mL cryovials. Cells were frozen at ~1oC per minute to –80oC 
and transferred into liquid nitrogen for long-term storage until of implantation. To 
thaw MPCs prior to grafting, basal media (expansion media without PDGF-BB, 
EGF, FBS, and penicillin/streptomycin) was pre-warmed to 37oC, and 9 ml of the 
warmed media was placed into a 15 ml conical centrifuge tube.  Vials of frozen 
MPCs were thawed in a 37oC water bath for approximately one minute, after 
which cells were transferred to the pre-warmed medium. The cell number was 
counted to reach 50 million by hematocytometer and trypan blue was used to 
check cell viability during the counting. MPCs were washed by 2x PBS and spun 
down at 400g for 5 minutes and resuspended in 2 ml saline. A small fraction of 
cells was replated in a T-150 flask to check the cell viability and percentage of 
Lac-z positive cells. Cells used for transplantation were >80% viable.  MPCs 
conditioned medium in the subsequent experiments was harvested 24 h after 
culture. As a control, a portion of the medium was incubated for 24 h without 
MPCs. 
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Myocardial Ischemia/Reperfusion Model and transarterial stem cell 
injection  Young Yorkshire female swine (~20 kg; Manthei Hog Farm, Elk River, 
MN) were anesthetized with pentobarbital (30 mg/kg iv), intubated and ventilated 
with a respirator with supplemental oxygen. Left heart catheterization was 
performed. Myocardial infarction was created by balloon occlusion of the left 
anterior descending coronary artery (LAD) distal to the second diagonal for 60 
minutes followed by reperfusion after anticoagulation. The trans-arterial catheter 
(Microsyringe infusion catheter from Mercator MedSystems, CA) was then placed 
in the same coronary artery and either stem cells at 50 million cell/mL (n=6) or 
saline (n=6) were injected. The intra myocardial position of the needle was 
confirmed under fluoroscopy in the cardiac catheter Laboratory with 
contrast diluted in both placebo and cell injection to confirm delivery outside of 
vessel lumen.  Five equal injections for a total of 50 million MPC were injected 
with final volume of one mL.  If ventricular fibrillation occurred, electrical 
defibrillation was performed immediately. Animals received standard post-
operative care including analgesia until they ate normally and became active.  
 
MRI Methods   Animals were examined at baseline, 1 week post 
infarction and then 4 weeks with MRI. MRI was performed on a 1.5 Tesla clinical 
scanner (Siemens Sontata, Siemens Medical Systems, Islen NJ) using a phased-
array 4-channel surface coil and ECG gating.  Animals were anesthetized with 
1% isoflurane and positioned in a supine position within the scanner. The 
protocol consisted of: 1) localizing scouts to identify the long- and short-axis of 
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the heart, 2) short- and long-axis cine for the measurement of global cardiac 
function, and 3) delayed contrast-enhancement for the assessment of scar size. 
Steady-state free precession “True-FISP” cine imaging used the following MR 
parameters: TR = 3.1 ms, TE = 1.6 ms, flip angle = 79o, matrix size = 256 x 120, 
field of view = 340 mm x 265 mm, slice thickness = 6 mm (4 mm gap between 
slices) and 16-20 phases were acquired across the cardiac cycle.  Global 
function and regional wall thickness data were computed from the short-axis cine 
images using MASS (Medis Medical Imaging Systems, Leiden, The Netherlands) 
for the manual segmentation of the endocardial and epicardial surfaces at both 
end-diastole (ED) and end-systole (ED) from base to apex. Short-axis 
turboFLASH imaging, from base to apex, used TR = 16 ms, TE = 4 ms, TI ~ 220 
ms, flip angle = 30o, matrix size = 256 x 148, field of view = 320 mm x 185 mm, 
slice thickness = 6 mm (0 mm gap between slices) and two signal averages.  The 
appropriate inversion time (TI) was chosen to adequately null the signal intensity 
(SI) of normal myocardium.  Infarct size was calculated from the delayed 
contrast-enhanced images using MASS to manually segment regions of non-
viable tissue.  Infarct size was calculated as the ratio of the total scar area to the 
total LV area.  
 
Spatially localized 31P-MR spectroscopy technique   Animals returned 
to the laboratory for final open chest MR spectroscopic study 4 weeks after 
myocardial infarction. Magnetic field shimming to improve the magnetic field 
homogeneity of the heart was achieved by the “auto-shim” scheme (Varian 
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Assoc. Inc., CA).  Spatially localized 31P NMR spectroscopy was performed using 
the RAPP-ISIS/FSW method [54, 89-91], which is the rotating-frame experiment 
using adiabatic plane-rotation pulses for phase modulation (RAPP)-imaging-
selected in vivo spectroscopy (ISIS)/Fourier series window (FSW) method. 
Detailed experiments documenting voxel profiles, voxel volumes and spatial 
resolution attained by this method have been published previously.  In this 
application of RAPP-ISIS/FSW, the signal origin was first restricted to a 12*12 
mm two-dimensional column perpendicular to the LV wall.  The signal was later 
localized into three well resolved and five partially resolved layers along the 
column and hence, across the LV wall.  Localization along the column was based 
on B1 phase encoding and employed a 9-term Fourier series window as 
previously describe [54, 89-91].  The phase encoded data were used to generate 
a voxel or a "window" that can be shifted arbitrarily by post data acquisition 
processing along the phase encode direction (in this case perpendicular to the 
surface coil and thus the heart wall); consequently, voxels were generated at 
different distances or "depths" from the outer LV wall.  However, we normally 
present five voxels centered about 45°, 60°, 90°, 120°, and 135° phase angles as 
previously described.  There is absolutely no overlap between the 135° voxel 
(corresponding to the subepicardium) and the 45° voxel (corresponding to the 
subendocardium). Whole wall spectra were obtained with the image-selected in 
vivo (ISIS) technique, defining a column 12*12 mm2 perpendicular to the heart 
wall.  The calibration of spectroscopic parameters was facilitated by placing a 
polyethylene capillary filled with 15 µl of 3 M/L phosphonoacetic acid into the 
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inner diameter of the surface coil. This phosphonoacetic acid standard was used 
only for calculating the 90 degree pulse length of the RAPP-ISIS method [54, 89-
91]. The position of the voxels relative to the coil was set according to the B1 
strength at the coil center which was experimentally determined in each case by 
measuring the 90° pulse length for the phosphonoacetic acid standard contained 
in the reference capillary at the coil center. NMR data acquisition was gated to 
the cardiac and respiratory cycles using the cardiac cycle as the master clock to 
drive both the respirator and the spectrometer as previously described [54, 89-
91]. The surface coil was constructed from a single turn copper wire 25 mm in 
diameter with each side of the coil leads soldered to a 33 pF capacitor. Complete 
transmural data sets were obtained in 10-minute time blocks using a repetition 
time of 6-7 seconds to allow for full relaxation for ATP and inorganic phosphate 
(Pi) and approximately 95% relaxation of the PCr resonance [54, 89-91].  The 
ratios of PCr to ATP (PCr/ATP) were calculated for each transmurally 
differentiated spectra set as previously described [54, 89-91]. All resonance 
intensities were quantified using integration routines provided by the SISCO 
software.  
 
1H- NMR spectroscopy technique  1H NMR methods have been previously 
reported in detail [54, 92]. In brief, radiofrequency (RF) transmission and signal 
detection were performed with the dually tuned 28 mm diameter surface coil. A 
single-pulse-collection sequence with a frequency selective Gaussian excitation 
pulse (1ms) was used to selectively excite the N-δ proton resonance signal of the 
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proximal histidine in deoxymyoglobin (Mb- δ). This technique provided sufficient 
water suppression due to the large chemical shift difference between water and 
Mb- δ (>14 kHz). The NMR signal was optimized by adjusting the RF pulse 
power using the water signal as a reference.  A short repetition time (TR = 25 
ms) was used due to the short T1 of Mb- δ. Each spectrum was acquired in 5 min 
(10,000 FIDs).  Although the short T1 of Mb- δ and fast acquisition prevent gating 
to the cardiac cycle, the signal loss due to motion is negligible compared to the 
inherently broad line width of the Mb- δ peak. 
 
Surgical preparation for open chest MR spectroscopy study   Detailed 
surgical preparations for MRS study are published previously [56, 77, 91]. Briefly, 
animals were anesthetized with pentobarbital (30 mg/kg followed by a 4 mg/kg/hr 
iv), intubated and ventilated with a respirator and supplemental oxygen.  Arterial 
blood gases were maintained within the physiologic range by adjustments of the 
ventilator settings and oxygen flow. 3.0 mm OD heparin-filled polyvinyl chloride 
catheters were inserted into the ascending aorta (Ao) and inferior vena cava (IV). 
A sternotomy was performed, and the heart was suspended in a pericardial 
cradle.  A third heparin-filled catheter was introduced into the LV through the 
apical dimple and secured with a purse string suture.  A 25 mm diameter NMR 
surface coil was sutured onto the anterior wall of the LV adjacent to the infarct 
region.  The pericardial cradle was then released, and the heart was allowed to 
assume its normal position in the chest.  The surface coil leads were connected 
to a balanced-tuned external circuit and the animals positioned within the 
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magnet. Hearts with post infarction LV remodeling are very sensitive to 
alterations of loading conditions of the LV, and that subtle differences in LVEDP 
or LVSP could affect myocardial contractile performance measurements. In order 
to compensate for insensible fluid loss in the open chest studies, we routinely 
administer saline at rate of 1 ml/min i.v. during the entire experimental data 
acquisition. Ventilation rate, volume and inspired oxygen content were adjusted 
to maintain physiologic values for arterial PO2, PCO2 and pH.  Aortic and LV 
pressures were monitored continuously throughout the study.  Hemodynamic 
measurements were acquired simultaneously with the 1H - and 31P- MR spectra.   
 
MR spectroscopy study protocol and hemodynamic measurements 
Hemodynamic measurements were acquired simultaneously with the NMR 
spectra.  Aortic and LV pressures were measured using pressure transducers 
positioned at mid-chest level [89-91] and recorded on an 8-channel recorder. 
After all the baseline data were obtained, animals received combined 
dobutamine and dopamine infusion (20 μg/kg/min. each) to induce a very high 
cardiac workstate.  After waiting for approximately 5 minutes after the initiation of 
catecholamine infusion, all the spectroscopic and hemodynamic data were again 
measured under the high cardiac workstates.  
 
Tissue preparation   The LV was sectioned in a bread-loaf manner into 6 
transverse sections (~ 10 mm in thickness) from apex to base. Even rings were 
subdivided into 12 circumferential specimens and fixed in zinc fixative (Anatech 
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LTD, Battle Creek, MI, USA) for Haematoxylin & Eosin (HE), 
immunofluorescence staining and engraftment evaluation. 
 
Engraftment evaluation   Each of the 12 pieces of cardiac tissue of a 
short axis ring were stained by X-gal (Invitrogen) and embedded in Tissue-Tek 
OCT (Fisher Scientific). Serial cryostat sections (10µm in thickness) were 
obtained from the whole transverse even rings. Engrafted MPCs were identified 
by counting the X-gal-positive nuclei in every 10th serial section of the whole 
transverse ring and then multiplying by 10 to obtain the total number of engrafted 
MPCs per ring. The total number of engrafted MPCs equals two fold x-gal 
staining positive cells in all three even rings. The engraftment rate of transplanted 
MPCs was calculated by dividing the total number of engrafted MPCs by 50 x 106 
(the number of MPCs injected) and multiplying by 100%. 
 
Immunohistochemistry   Detailed immunohistochemistry methods are 
described previously [85, 93]. Briefly, cryostat sections (10µm thickness) were 
obtained for immunofluorescence staining to evaluate myocyte or endothelial 
differentiation of injected cells. Antibodies used included Troponin T (cardiac 
isoform Ab-1, Lab Vision Corp. Chicago, IL), α-sarcomeric actin, N-cadherin, and 
CD31 (Research Diagnostic Inc. Flanders, NJ). Nuclear counterstaining was 
performed with 4’,6’-diamino-2-phenylindole (DAPI, Molecular Probes, Grand 
Island, New York).  
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Analysis of Myocardial Vascular Density   Vascular density was 
assessed by staining with anti-CD31 (BD Biosciences, San Diego) antibody. The 
sections were visualized using fluorescence-labeled secondary antibody 
(Molecular Probes Inc., Eugene, OR). Images were taken at a magnification of 
X20 using an Olympus microscope (BX51/BX52; Tokyo). The number of 
capillaries were counted in a blind fashion in three fields per each section of the 
peri-infarct zone, and total of five sections per ring were analyzed (n = 4 for each 
group). The quality of the computer analysis (Image J) was checked against 
manual counting. 
 
HL-1 myocyte culture and apoptosis   HL-1 myocytes (from Claycomb 
Laboratory, University of Louisiana) were cultured as previously described [85]. 
Briefly HL-1 cells were plated onto fibronectin-gelatin-coated plates or flasks and 
cultured in Claycomb medium supplemented with 10% fetal bovine serum, 100 
U/ml penicillin, 100 µg/ml streptomycin, 0.1 mM norepinephrine, and 2 mM L-
glutamine. For the coculture experiment, HL-1 cells were plated in 12-well plates 
at a total density of 5 x 105 (1:3 ratio of MPCs to HL-1 cells) in half MPC medium 
and half Claycomb medium. Before being cocultured, HL-1 cells were labeled 
with Vybrant CFDA SE cell tracer kit (Molecular Probes). Labeled HL-1 cells were 
extensively washed and cocultured with MPCs. The coculture and HL-1 cells 
alone were treated with 40ng TNFα for 18 h. Apoptosis was assessed by staining 
with Hoechst 33342 (H33342 ) dye and then quantifying the percentage of 
 apoptotic nuclei (300 cells counted per sample) in the CFDA-labeled subset by 
identifying cells with H33342 staining [85]. 
 
Identification of angiogenic factors released from the stem cells   The 
cultured MPCs were divided into two subgroups (5x104cell/per group). One MPC 
group was exposed to 2% oxygen (hypoxia). The other group was cultured in 
normoxic condition.  Eighteen hours later, the unconcentrated supernatants were 
subjected to ELISA assay for VEGF and Insulin like growth factor (IGF) contents 
according to manufactures’ instructions, respectively. 
 
  Mitochondrial membrane potential ( m) changes detection   HL-1 
cells were plated on chamber slides and the next day cells were stained with 
Hoechst 33342 (H33342) dye. After thoroughly washing three times, MPCs were 
plated onto the chamber slides (1:1 ratio). After 12 hours, the cells were treated 
with 40ng tumor necrosis factor α (TNFα) for 6 hours. Mitochondrial inner-
membrane potential changes were evaluated using Mitochondria staining kit 
according to the manufacturer’s directions (Sigma-aldrich, Saint Louis, 
Missouri).The cationic, lipophilic dye, JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-
tetraethybenzimidazolocarbo-cyanine iodide) aggregates can be visualized in the 
mitochondria as bright red flurorescence, representing intact mitochondria and 
JC-1 monomers as green flurorescence, which represent disrupted mitochondria. 
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MPCs cocultured with neonatal cardiomyocytes and Cytochrome C 
release   Primary cultures of cardiac myocytes were prepared by enzymatic 
digestion of ventricles obtained from neonatal (2 day old) Sprague-Dawley rats as 
previously described [93]. Coculture experiments were set up in the fibronectin-
coated chamber slides at a total density of 2×104(1:1 ratio; cardiomyocytes: 
MPC) in MPCs medium supplemented with 2% FBS, 100 µg/ml of penicillin, and 
250 µg/ml of streptomycin at  37 °C in humid air with 5% CO2. Cytochrome C 
release was detected by immunofluroscence staining using anti-cytochrome C 
antibody after cardiomyocytes and the coculture cells were treated with 40 ng 
TNFα. Troponin T was used to stain cardiomyotyes. Double staining positive 
cardiomyocytes were detected and counted. 
 
Statistics and Data analysis   Anatomic data, wall stress data, capillary 
density and the in vitro apoptosis data were compared between the two groups 
(MI and MI + cell) using the Student t-test. The repeated measures ANOVA was 
applied to compare the measurements of systolic thickening fraction, ejection 
fraction and scar size across two treatment groups (MI and MI + cell) and 
different time points (before MI, 1 week, and 4 week after MI) and to compare the 
measurement of myocardial PCr/ATP and hemodynamic data across two 
treatment groups (MI and MI + cell) and two hemodynamic conditions (baseline 
and after inotropic stimulation). For comparison between the two treatment 
groups, the conventional significance level of type I error    (P < 0.05) was used. 
The Bonferroni correction for the significance level was used to take into account 
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multiple comparisons. All values are expressed as mean ± standard deviation 
(SD). All statistical analyses were performed in Sigmastat version 3.5 (San Jose, 
CA).  
The authors had full access to the data and take responsibility for its 
integrity. All authors have read and agree to the manuscript as written. 
 
RESULTS 
Anatomic and Hemodynamic Data   Four of the 16 pigs with LAD 
occlusion and reperfusion died within the first 60 minutes after coronary 
occlusion due to ventricular fibrillation. The surviving 12 pigs were randomized to 
receive either MPC (n=6) or saline only (n=6). The anatomic data for the 12 
swine with LAD ligation is summarized in Table 1. The degree of LVH as 
reflected by LVW/BW and RVW/BW was not significantly different between the 
MPC and saline group. The hemodynamic data at baseline and at increased 
workload are summarized in Table 2. Inotropic stimulation caused a significant 
increase in the heart rate and left ventricular systolic pressure and consequently 
rate-pressure product. However, there was no significant difference between the 
swine with cell treatment versus swine without cell treatment. 
 
Global Functional Data   The temporal changes in global function as 
measured by MRI are depicted in Figure 1. There was no significant difference 
between the two groups at baseline. At week 1, the distal LAD occlusion caused 
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a similar scar size in both groups with significant decrease in LV ejection fraction 
(EF), with no significant difference between the two groups. However, there was 
a remarkable LV chamber functional recovery from 1 week to 4 weeks after cell 
transplantation (EF, 46.3±6.6 vs. 33.3±3.1, p<0.001), which was not observed in 
the control group (Figure 1a). Thus, at week 4, the LVEF was significantly higher 
in the cell treated animals as compared to control animals (46.3±6.6 vs. 
35.4±3.2, p<0.001) (Figure 1a). This functional improvement in the MPC 
treatment group was accompanied by a significant decrease in scar size at 4 
weeks compared with saline group (4.8±1.9 vs. 8.8±2.1, p=0.047). It should be 
noted that there was a significant decrease in the scar size from week 1 to week 
4 in the cell treated group (4.8±1.9 at 4 week vs. 9.2±3.5 at 1 week, p<0.001) 
(Figure 1b). 
 
Regional Contractile Functional Data   The left ventricle was divided 
into 16 segments. The apex was divided into 4, mid-LV into 6 and base into 6 
segments. Distal LAD occlusion resulted in a thin walled infarct in the apex 
mainly in the anteroseptal segments (segments 1 and 2). The remaining apical 
segments (segments 3 and 4) are the border zone and the mid LV and base 
make up the remote zone. Systolic thickening fraction was measured as a 
surrogate marker of regional left ventricular contractile function. Distal LAD 
occlusion alone resulted in systolic bulging of the infarct zone at 1 week which 
persisted at 4 weeks (Table 3). MPC treatment resulted in increased systolic 
thickening fraction of the infarct and border zone at 4 weeks as compared to 
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control (Table 3). Moreover, the systolic thickening fraction in the infarct and 
border zone within cell treated animals was significantly increased at 4 weeks as 
compared to 1 week (Table 3). LV wall stress (σ) in different LV segments at 4 
weeks was calculated according to the Laplace law, as previously described, 
using the following equation: σ = PR/(2T) [57], where P is LV pressure, R is 
chamber radius, and T is wall thickness measured from CINE MRI images in the 
particular region of the LV. MPC treatment resulted in a significant decrease in 
wall stress in the infarct (300±16 mmHg in Control vs 208±20 mmHg in MPC 
treated, p=0.009) and border zone (242±18 mmHg in Control vs 174±14 mmHg 
in MPC treated animals, p=0.01). 
 
Myocardial high-energy phosphate (HEP) and Pi levels   Myocardial 
HEP and Pi levels are reflected by the PCr/ATP ratios as shown in Figure 2. The 
PCr/ATP ratio is significantly higher at 4 weeks in the pigs treated with MPC as 
compared to those without treatment (2.03±0.31 vs 1.53±0.28, p=0.009). After 
increased workload, the PCr/ATP ratio decreased in both groups but was still 
significantly higher in the cell treated pigs (1.80±0.24 vs 1.43±0.25, p=0.027). No 
deoxymyoglobin resonance peak was detected in either group using 1H-MRS, 
which supports our previous findings that the border zone bioenergetic 
abnormalities in hearts with postinfarction LV remodeling are not caused by a 
persistent myocardial ischemia.  
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Cell engraftment and differentiation in Vivo   Cell engraftment was 
determined by counting β-galactosidase staining positive cells in tissue sections 
and cell engraftment rate was calculated as a percentage of engrafted cells out 
of a total 50 million injected stem cells. Two additional pigs were sacrificed at 10 
days post MI and cell transplantation to assess for engraftment at an earlier time 
period. Ten days after cell transplantation, the cell engraftment rate was about 
5%. Most of the cells were retained in the infarcted area and only a small portion 
of the engrafted cells resided in the peri-infarct and remote areas (Figure 3a). 
Four weeks after cell transplantation, cell engraftment rate was remarkably 
decreased and reached 0.55% (n=6). To determine the differentiation of 
engrafted cells, tissue sections were double-stained for ß-galactosidase and 
cardiac-specific markers, including troponin T, α-sarcomeric actin, and N-
cadherin. We found that approximately 2% of engrafted cells costained positive 
for ß-galactosidase and troponin T or α-sarcomeric actin 10 days after cell 
transplantation (Figure 3b, 3c). These double staining positive cells were only 
observed in the peri-infarct and remote areas. Among the cells that costained 
positive for ß-galactosidase or α-sarcomeric actin, we identified gap junctions 
between the cells as indicated by N-cadherin immunoflurescence staining (Figure 
3b). These data suggest that transplanted MPCs engraft successfully and can 
undergo in vivo transdifferentiation into cardiomyocyte-like cells or form fused 
cells. 
 
 37 
Vascular Density   To determine the mechanisms underlying the 
beneficial effects of MPC transplantation, we investigated the effects of MPC 
transplantation on neovascularization and angiogenesis in the post-MI hearts.  At 
4 weeks after cell transplantation, immunofluorescence staining for CD31 
antibody indicated significant angiogenesis in stem cell treated hearts, with more 
CD31 expressing capillaries being present in peri-infarct regions of cell treated 
compared with saline-treated hearts (Figure 4a). Quantitative evaluation of CD31-
positive capillary numbers per high-power field (20x) indicated that vascular 
density was significantly greater in the MPC treated group than the saline-treated 
group (Figure 4a, b). However, few cells were staining positive for both the 
endothelial cell marker CD31 and ß-galactosidase (data not shown). These data 
suggest that transplanted MPCs may promote angiogenesis through a paracrine 
effect.  
To further identify the angiogenic factors, we determined the levels of 
VEGF and IGF in the conditioned medium under different culture conditions. We 
found that MPCs can secrete detectable VEGF in normoxic conditions, which 
was significantly increased in response to hypoxia (Normoxia, 456.1+/-
104.1pg/5x104cell; hypoxia, 1543.8+/-77.1pg/5x104cell, n=5, P<0.001). However, 
the IGF levels secreted under both conditions were too low to be detected. These 
data suggest that MPCs secrete VEGF that is an important angiogenic factor 
contributing to the observed cellular therapy associated beneficial effects.  
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The protective effect of MPCs on mitochondrial membrane potential.  
To investigate the protective effect of MPCs on cardiomyocytes, HL-1 myocyte 
apoptosis was induced by inflammatory factor TNFα. Coculture of HL-1 cells with 
MPCs significantly inhibited TNFα induced apoptosis (HL-1+TNFα, 32+/-3; 
TNFα+coculture, 14+/-1%; n=6, p<0.001)(Figure 5a). To further determine its 
underlying mechanisms, the alteration in mitochondrial inner-membrane 
electrochemical potential was determined by staining with the cationic, lipophilic 
dye, JC-1. MPCs significantly inhibited TNFα induced HL-1 cell mitochondrial 
membrane potential changes (Figure 5b). Co-cultured MPCs with neonatal 
cardiomyocytes also inhibited TNFα induced cytochrome c release from neonatal 
cardiomyocytes (Figure 5c). These data suggest that the paracrine factors 
secreted by MPCs play a protective role in preventing myocytes from apoptosis. 
 
DISCUSSION 
 
The present study demonstrates that MPC transplantation through a trans-
coronary arterial catheter approach is safe, feasible and effective. MPC 
transplantation is associated with increase in vascular density, inhibition of 
apoptosis and reduction of infarct size, which is accompanied by improvement in 
border zone and infarct zone contractile function, with consequent improvement 
in myocardial bioenergetics and global LV function.  These functional beneficial 
effects were observed despite a low engraftment of MPCs at 4 weeks.  In vitro, 
the MPCs significantly inhibited TNFα induced mitochondrial membrane potential 
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change and cytochrome C release from myocytes. Additionally, coculture of 
MPCs with HL-1 cells inhibited TNFα induced apoptosis. Thus, the MPC induced 
“trophic effect” results in structural changes that are characterized by increased 
vascular density, spared myocytes from apoptosis and decreased infarct size, 
which in turn, leads to the improvement of BZ myocardial contractile 
performance, amelioration of regional wall stress and myocardial bioenergetics.   
 
Stem cell delivery via trans-arterial injection. Although clinical trials of 
intra-coronary artery infusion of stem cells have shown moderate LV functional 
improvement [41-42, 44, 46], a report of a dog study suggested that coronary 
artery infusion of stem cells resulted in blockage of small vessels, which in turn 
caused discrete micro-myocardial necrosis [87]. In the present study, we 
employed a trans-arterial catheter with a micro-needle that penetrates the 
coronary artery wall and injects stem cells directly into the myocardium that is 
exposed to ischemia and reperfusion.  We found similar engraftment of stem 
cells as previous studies using open heart direct intra myocardial injection [77, 
94]. These data demonstrate that trans-coronary injection of MPCs through this 
technique is safe and leads to the improvement in left ventricular function. 
 
Contractile performance in the infarct border zone. Increased LV wall 
stress in the border zone has been implicated among the factors attributing for 
left ventricular remodeling after myocardial infarction [56, 95]. It has been shown 
in a porcine model that myocardial infarction leads to dyskinesis in the infarct 
 40 
region and hypokinesis in the infarct border zone [56]. MPC transplantation 
caused an improvement in infarct and border zone systolic thickening fraction in 
the present study (Table 3), which in turn, effectively reduced wall stress (border 
zone wall stress was 242±18 mmHg in Control vs 174±14 mmHg in MPC treated 
animals, p=0.01) and consequently improved the mismatch of energy delivery 
and demand (Figure 2) [77, 94]. The contractile performance improvement in the 
BZ is likely based on the myocardial structural improvements that are 
characterized by increased vascular density (Figure 4) and reduced apoptosis 
(Figure 5) in the BZ, and myocyte differentiation (Figure 3).   
 
Border Zone Myocardial Energetics  Post infarction LV remodeling is 
associated with decreased high energy phosphates, PCr/ATP and expression of 
several proteins crucial to oxidative ATP production and these abnormalities are 
most severe in the borderzone [56].Our study confirmed these reports and 
showed that these abnormalities are worsened during catecholamine stimulation 
induced high cardiac workstate (Figure 2). The improved myocardial 
bioenergetics in response to the stem cell transplantation was also supported by 
the in vitro experiments indicating that mitochondrial inner-membrane 
electrochemical potential was significantly improved (Figure 5b), which could 
effectively increase the mitochondrial oxidative phosphorylation potential.  This 
improvement in mitochondrial function may have an important role in cell survival 
and inhibition of the apoptotic pathway in resident cardiac progenitors. 
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Effect of cell transplantation on infarct size  Sequential MRI functional 
assessment allowed us to conclude that the infarct size in swine treated with 
MPC decreased from 1 week to 4 week interval, while the scar sizes in swine 
without MPC treatment was maintained throughout the follow-up (Figure 1b). 
This reduction in scar size with stem cell treatment has been seen previously in 
other reports [78, 83]. The beneficial effects of MPC transplantation could be 
related to MPC differentiation into cardiomyocytes [11] or mobilization of 
endogenous progenitors to the injury site by paracrine effects [83]. Recently, it 
has been shown that endogenous cardiac progenitor cells upon activation can 
home to the infarcted myocardium and help in myocardial regeneration [96-99]. 
In the present study, less than 1% of transplanted MPC cells engrafted at 4 
week, and even a smaller percentage expressed markers of cardiomyocytes. 
This suggests that the functional and bioenergetic improvements are likely 
secondary to paracrine effects.  The data from the present study indicates a 
“trophic effect” that is the cytokines released from the engrafted stem cells act 
upon the host myocytes and spare them from apoptosis.  
  
Stem cells induced Anti-Apoptosis effect   Apoptosis does occur in 
failing hearts [100]. Mitochondrial release of cytochrome c has been implicated in 
apoptosis induced by TNF-α [101]. Mesenchymal stem cell transplantation has 
been shown to have significant anti-apoptosis effects [80, 82-83]. Data from the 
present study supports this hypothesis and further elucidates this finding by 
showing that MPC co-cultured with neonatal rat cardiomyocytes inhibits TNF-α 
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induced cytochrome c release. Mitochondria serve a central role in apoptotic 
pathways. It has been shown that the mitochondrial respiratory chain (MRC) 
complex I is inhibited in the early phase of TNFα induced apoptosis [101]. 
Inhibition of complex I can affect electron flow through the other complexes of the 
mitochondrial oxidative physporylation leading to cytochrome c release and 
caspase 3 activation followed by the reduction of mitochondrial membrane 
potential. The data from the present study demonstrates that the TNFα induced 
loss of mitochondrial membrane potential can be inhibited by stem cell treatment. 
The improvement in myocardial energetics in vivo with MPC treatment observed 
in the present study indicates that the impairment in mitochondrial respiratory 
chain, F0F1 ATP synthase and ATP production are ameliorated by MPC 
treatment.  
 
Stem cell induced neovascularization   We hypothesized that the 
mechanism for improvement in ventricular function in response to MPC 
transplantation is partially due to neovascularization.  MPC treated animals 
demonstrated a significant increase in vascular density as compared to animals 
which received saline (Figure. 4). This generation of new coronary vessels after 
ischemic injury is very important clinically as it leads to increased blood flow to 
the infarct and border zone [102], and consequently spares ischemia threatened 
myocytes from apoptosis leading to improved ventricular function.  The 
neovascularization is probably related to both an increase in angiogenesis and 
vasculogenesis. Previously, we reported that vasculogenesis as evidenced by 
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endothelial differentiation from MPC did contribute to the increased vascular 
density although only 3% of the engrafted MPCs differentiate into endothelial 
cells [77]. In our present study, we observed insignificant endothelial 
differentiation of transplanted MPCs 4 weeks after the cell transplantation. Thus, 
it seems that the endothelial differentiation from MPCs has minimal effect on 
vasculogenesis. However, it is possible that the MPC transplantation results in 
recruitment of endogenous cardiac or bone marrow endothelial progenitor cells 
(EPCs) that leads to vasculogenesis and contributes to the increased vascular 
density (Fig. 4 Panel B). In addition, it has been recently demonstrated that 
transplantation of cardiac progenitor cells (CPCs) induces neovascularization 
primarily through vasculogenesis [102]. Data from the present study 
demonstrates that MPCs secrete a significant level of VEGF under normoxic 
conditions, which was further increased in response to hypoxia.  It has been 
previously reported that VEGF secretion by MSCs is a potent angiogenic factor 
to promote neovascularization as well as inhibit apoptosis [103].   Taken 
together, these data suggest that VEGF plays an important role in myocardial 
protection that is associated with MPC transplantation. 
    
In summary, the present study demonstrates that trans-coronary artery 
injection of MPCs in a porcine model of ischemia/reperfusion resulted in 
improvement of myocardial contractile function, reduction of BZ wall stress, 
limitation of the scar size expansion and balance of myocardial energy delivery 
and demand.  Since the engraftment rate is low and myogenic differentiation is 
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even lower, the beneficial effects are most likely related to the “trophic effects” of 
MPCs on the host myocardium, which include promotion of angiogenesis, 
maintenance of mitochondrial integrity, and inhibition of apoptosis of ischemia 
threatened and overstretched myocytes in the BZ myocardium.     
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FIGURE LEGENDS 
 
Figure 1. The functional and structural improvements 4 weeks after MPC 
transplantation into myocardial infarction hearts.   A: MPC transplantation into 
the border zone myocardium in a swine ischemia/reperfusion model significantly 
attenuated the deterioration of cardiac function. B: MPC transplantation into the 
border zone myocardium in a swine ischemia/reperfusion model significantly 
limited the scar size expansion following myocardial infarction at 4 weeks. Data 
are mean+/-SD; n=6 in each group. Pair-wise p values are derived from repeated 
measures ANOVA with Bonferroni correction. 
 
Figure 2.  MPCs transplantation into the border zone myocardium significantly 
improved LV bioenergetics as reflected by altered myocardial PCr/ATP 4 weeks 
after MI at baseline and high work states. Data are mean+/-SD; n=6 in each 
group. Pair-wise p values are derived from repeated measures ANOVA with 
Bonferroni correction. 
 
Figure 3. Histological staining of the tissues from the heart 10 days after 
transplantation of retrovirus lacZ labeled swine MPCs.  A: H&E staining of the 
tissues from the heart 10 days after transplantation of retrovirus lacZ labeled 
swine MPCs.  Panel (a) shows that the engrafted cells (LacZ) are distributed in 
peri-infarct and remote regions (magnification, x100); panel (b) shows the same 
sections at high magnification (magnification, x400). B: Engraftment and 
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differentiation of Swine MPCs in vivo. Swine MPCs labled with LacZ were 
injected into myocardial infarcted hearts via a transmural catheter delivery and 
the tissues were harvested and dissected into 10µm sections. Dissected samples 
were stained for LacZ (dark blue), troponin T (green), and/or N-cadherin (red). 
Nuclei were stained by DAPI (blue). Upper panel: Low magnification. Lower 
panel: High magnification. C: Engraftment and differentiation of Swine MPCs in 
vivo. Dissected samples were stained for LacZ (blue) and alpha sarcomeric actin 
(Green). Nuclei were stained by DAPI (blue). Left Panel: low magnification; Right 
Panel: high magnification.  
 
Figure  4. Transplantation of MPCs into myocardial infarction hearts significantly 
promoted angiogenesis which was probably mediated by release of VEGF. A: 
Immunoflurescence staining of tissues from myocardial infarction and MPC 
transplantation heart; B: Mean number of CD31 containing capillaries in border 
zone myocardium (n=6, p<0.01). Data are mean+/-SD. 
 
Figure 5.  The protective effect of MPCs on cardiomyocytes. A: Cocultured 
Swine MPCs with HL-1 cells significantly inhibited TNFα induced HL-1 cell 
apoptosis (n=6, P<0.001). Data are mean +/-SD. B: Swine MPCs cocultured with 
HL-1 cells significantly inhibited TNFα induced mitochondrial membrane potential 
changes. C: Swine MPCs cocultured with rat neonatal cardiomyocytes 
significantly inhibited TNFα induced cytochrome C release.  
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Table 1. Anatomic Data obtained 4 weeks after MI 
 
 
BW 
(kg) 
LVW 
(g) 
RVW 
(g) 
LV/BW 
(g/kg) 
RV/BW 
(g/kg) 
MI (n=6) 33±5 97±13 33±8 2.96±0.24 1.00±0.15 
MI + Cell 
(n=6) 
32±6 98±23 34±6 3.01±0.27 1.06±0.12 
 
Values are mean±SD; MI, myocardial infarction; n, number of pigs; BW, Body 
weight; LVW, Left ventricular weight; RVW, Right ventricular weight. 
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Table 2. Hemodynamic data obtained 4 weeks after MI 
 
HR 
(beats/min) 
Ao-S 
(mmHg) 
Ao-D 
(mmHg) 
Mean AoP 
(mmHg) 
LVSP 
(mmHg) 
LVEDP 
(mmHg) 
RPP x 103 
(mmHg.min-1) 
MI  
(n=6) 
       
Baseline 73±10 93±10 51±10 65±6 99±13 5±1 7.14±1.24 
DB+DP 135±26 124±19 54±14 77±11 151±18 7.5±2.9 20.51±5.15 
p-value 
within MI 
<0.001 NS NS NS 0.009 NS <0.001 
MI + Cell 
(n=6) 
       
Baseline 100±28 95±18 63±21 74±19 108±26 5±1 11.02±5.12 
DB+DP 148±23 110±29 63±16 79±19 148±28 6.7±2.6 21.58±3.87 
p-value 
within 
MI+Cell 
<0.001 NS NS NS 0.013 NS 0.001 
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Values are mean±SD; n, number of pigs; MI, myocardial infarction; DbDp, 
Dobutamine and Dopamine (each 20µg/kg/min intravenous); HR, heart rate; Ao-
S, aortic systolic pressure; Ao-D, aortic diastolic pressure; LVSP, left ventricular 
systolic pressure; LVEDP, left ventricular end diastolic pressure; RPP, rate 
pressure product (HR x LVSP); NS, Not significant; Repeated Measures ANOVA 
p value is not significant for the effect of cell treatment with inotropic stimulation 
(p=0.353). Pair-wise comparisons within groups are listed in the table.  
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Table 3. Systolic thickening fraction 1 week and 4 weeks after the MI measured by MRI 
 
 
Infarct Zone 
p-value 
within 
group 
 
Border Zone 
p-value 
within 
group 
 
Remote Zone 
p-value 
within 
group 
 
 
1 week 4 weeks  
 
1 week 4 weeks  
 
1 week 4 weeks  
MI 
 
-4.3±1.5 -4.5±1.3 0.927 
 
8.9±1.4 8.8±1.7 0.986 
 
27.9±3.0 30.9±5.7 NS 
MI + Cell 
 
1.0±3.9 17.3±2.9 <0.001 
 
12.3±2.8 24.1±5.5 0.005 
 
28.7±4.6 34.2±4.9 NS 
p-value 
between 
group 
 
0.031 <0.001  
 
0.229 <0.001  
 
NS NS  
 
Values are mean ± SD; n=6 in each group; Pair-wise p values are derived from repeated measures ANOVA with 
Bonferroni correction; NS=Not significant.  
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CHAPTER 4: LONG TERM FUNCTIONAL IMPROVEMENT AND GENE 
EXPRESSION CHANGES AFTER BONE MARROW DERIVED MULTIPOTENT 
PROGENITOR CELL TRANSPLANTATION IN MYOCARDIAL INFARCTION 
 
Mohammad Nurulqadr Jameel, Qinglu Li, Abdul Mansoor,  
Xiong Qiang, Aaron Sarver, Xiaohong Wang, Cory Swingen, Jianyi Zhang. 
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The study examined the long term outcome of cardiac stem cell 
transplantation in hearts with postinfarction left ventricular (LV) remodeling. 
Myocardial infarction (MI) was created by ligating the 1st and 2nd diagonal 
branches of the left anterior descending coronary artery in Miniature Swines. 
Intramyocardial injections of 50 million LacZ labeled bone marrow derived 
multipotent progenitor cells (MPC) was performed in the periscar region (Cell, 
n=7) immediately after MI, while in control animals (CONT, n=7) saline was 
injected. Functional outcome was assessed monthly for 4 months with MRI and 
31P MR spectroscopy. Engraftment was studied on histology and gene chip 
(Affymetrix) array analysis was used to study differential expression of genes in 
the two groups. MPC treatment resulted in improvement of ejection fraction as 
early as 10 days after MI (Cell, 43.4±5.1 % vs. CONT, 32.2±5.5 %; p<0.05). This 
improvement was seen each month and persisted to 4 months (Cell, 51.2±4.8 % 
vs. CONT, 35.7±5.0 %; p<0.05). PCr/ATP ratio improved with MPC 
transplantation, which was most pronounced at high cardiac workstates 
(Subendocardial PCr/ATP was 1.70±0.10 vs. 1.34±0.14, p<0.05). There was no 
significant difference in scar size (scar/LV area*100) at 10 days post infarction.  
However, at 4 months there was a significant decrease in scar size in the Cell 
group (Cell, 4.6±1.0 % vs. CONT, 8.6±2.4 %; p<0.05). No significant engraftment 
of MPC was observed. MPC transplantation was associated with a 
downregulation of mitochondrial oxidative enzymes and increased levels of 
MEF2a and ZFP91. In conclusion, MPC transplantation leads to long term 
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functional and bioenergetic improvement in a porcine model of postinfarction LV 
remodeling despite no significant engraftment of stem cells in the heart. MPC 
transplantation reduces regional wall stresses and infarct size and mitigates the 
adverse effects of LV remodeling as seen by a reduction in LV hypertrophy and 
LV dilatation and is associated with differential expression of genes relating to 
metabolism and apoptosis. 
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INTRODUCTION 
 
Stem cell transplantation has emerged as a potential therapy for limiting post-
infarction left ventricular (LV) remodeling and the consequent development of 
CHF in both animal [77-80] and clinical [39, 41-42, 44, 46] studies. Clinical 
studies have shown mixed results on LV function with stem cell therapy with 
some showing benefit [39, 41-42] and some no difference in left ventricular 
ejection fraction [43-44]. In the Bone marrow transfer to enhance ST-elevation 
infarct regeneration (BOOST) study, the treated group showed significant short 
term increase of LV ejection fraction at 6 months, but interestingly no difference 
between the two groups was present at 18 months [104]. Using a swine model of 
post myocardial infarction (MI) LV remodeling, we recently reported that 
transplantation of bone marrow derived multipotent progenitor cells (MPC) 
resulted in a significant improvement of cardiac function and correction of 
abnormal energy metabolism at one month following transplantation [77]. 
However, the long term effect after MPC treatment still needs to be defined. Dai 
et al showed in a rat myocardial infarction model that allogenic Mesenchymal 
stem cell (MSC) treatment led to an improvement in left ventricular function 4 
weeks after transplantation but this improvement was lost at 6 months [37]. 
However, they did find stem cell engraftment as late as 6 months and showed 
that these cells expressed markers that suggested endothelium and muscle 
phenotypes [37]. Long term studies of any stem cell type in large animal models 
of myocardial infarction are relatively scarce.  
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The mechanisms underlying the beneficial effects of stem cell treatment are also 
not well defined. Our lab and others have demonstrated a very low engraftment 
rate and even lower cardiomyocyte differentiation rate a few weeks after bone 
marrow stem cell transplantation [77, 81, 105]. Therefore, the direct contribution 
of regenerated myocytes to the improved cardiac contractile function appears 
less likely. Dzau’s group have shown a significant protection of stressed 
cardiomyocytes from apoptosis and consequent reduction in infarct size by 
injection of concentrated cell culture medium that was obtained from bone 
marrow derived MSCs with overexpression of Akt, or by injection of MSCs 
themselves into the myocardium at the time of acute myocardial infarction [81-
83].  Thus, the mechanisms underlying the long term outcome after stem cell 
transplantation also require more elucidation. 
 
The objectives of the present study are to determine the long term functional and 
bioenergetic outcome after MPC transplantation in a clinically relevant porcine 
model of postinfaction LV remodeling and whether these effects are related to 
persistent long term engraftment of MPC in the heart. We hypothesize that MPC 
transplantation leads to transient engraftment and secretion of factors that leads 
to long term myocardial gene expression changes which contributes to the 
beneficial functional outcome.  
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METHODS 
 
All experiments were performed in accordance with the animal use 
guidelines of the University of Minnesota, and the experimental protocol was 
approved by the University of Minnesota Institutional Animal Care and Use 
Committee (IACUC). The investigation conformed to the “Guide for the care and 
use of laboratory animals” published by the National Institutes of Health (NIH 
publication No 85-23, revised 1985). 
 
Study Design  The study design is depicted in Fig.1. A total of 14 swine 
were randomized after myocardial infarction to receive either 50 million stem 
cells (n=7) or saline only (n=7). The pigs were followed for a total of 4 months 
after transplantation with MRI occurring at baseline, 10 days, 1 month and then 
subsequently each month for 4 months. At the end of the study open-chest NMR 
spectroscopy was performed and then after sacrifice histology and microarray 
analysis was done on the tissue samples. 
 
Cell Culture   Bone Marrow Derived Multipotent Progenitor Cells (MPCs) 
were expanded from one of the established swMAPC (swine multipotent adult 
progenitor cell) cell lines generated as described previously in detail[88]. MPCs 
at population doubling 80 (~PD70) were transduced with a Lac-Z Retrovirus (RV) 
supernatant (Lac-Z RV supernatants were generated by co-transfection of pVSV-
G retroviral vector (BD Biosciences) and pCL-MFG-LacZ RV packaging vector 
 62 
(Imgenex) using the calcium phosphate method (BD Bioscience, K2051-1) in GP-
293 cell line (BD Bioscience)). Large scale expanded and LacZ transduced cells 
expressed low to non-detectable Oct-4 mRNA.  These MPC cells have previously 
been shown to differentiate along different cell lineages [77].  
 
The transduced swine cells were expanded using the following methods. Cells 
were cultured in 60% DMEM-LG / 40% MCDB-201 supplemented with 1x ITS, 
0.5x LA-BSA, 0.1mM L-ascorbic acid 2-phosphate, 100U penicillin and 1,000U 
streptomycin, 50 nM dexamethasone and 2% pre-screened FBS with 10 ng/ml 
each human PDGF-BB and human EGF and passaged every 2 to 3 days through 
removal of the growth media and addition of 5 ml 0.25% trypsin per T150 flask. 
After rocking the flask to coat the bottom of the flask with trypsin, the cells were 
incubated at room temperature for 1 minute. Each flask was tapped lightly and 1 
ml of FBS was then added. Cells were removed and cells were combined into a 
50 ml conical tube. Flasks were rinsed with 10 ml PBS and this volume added to 
cells. Cells were pelleted through centrifugation at 400×g’s for 5 minutes, and 
after removal of the supernatant the cells were resuspended in 1 ml of complete 
medium and counted using a hemacytometer. Flasks were routinely seeded at 
500 cells/cm2 in flasks coated with 10ng/ml fibronectin A with 10ml media per T 
150 flask. After an initial placement of the flasks at 37 ºC, 5.5% CO2 overnight, 
the media was removed and replaced with fresh media and cells incubated 
another 2 days before passaging. 
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MPCs were harvested, centrifuged and resuspended at 10 million cells / 1 ml 
cryo preservation solution that consists of 70% growth media, 20% FBS, and 
10% DMSO in 1 mL cryovials. Cells were frozen at ~1oC per minute to –80oC 
and transferred into liquid nitrogen for long-term storage until of implantation.  To 
thaw MPCs prior to grafting, basal media (expansion media without PDGF-BB, 
EGF, FBS, and penicillin/streptomycin) was pre-warmed to 37oC, and 9 ml of the 
warmed media was placed into a 15 ml conical centrifuge tube.  Vials of frozen 
MPC were thawed in a 37oC water bath for approximately one minute, after 
which cells were transferred to the pre-warmed medium. The cell number was 
counted to reach 50 million by hematocytometer and trypan blue was used to 
check cell viability during the counting. MPC were washed by 2x PBS and spun 
down at 400g for 5 minutes and resuspended in 2 ml saline. A small fraction of 
cells was replated in a T-150 flask to check the cell viability and percentage of 
Lac-z positive cells. Cells used for transplantation were >80% viable.  
 
Animal Model and stem cell delivery method  Sinclair Miniswine 
(Sinclair Research Center, MO) were used for this study. Sinclair pigs are 
research purpose bread, and grow very slowly which allowed us to follow these 
animals for long term.  These pigs have a shorter lifespan as compared to 
humans, so 4 months is equivalent to a longer follow-up in human years. The 
follow-up of 4 months was also chosen because the bore size of the 4.7T magnet 
for the magnetic resonance spectroscopy studies limits us to perform these 
studies on larger animals. The postinfarction LV remodeling model was created 
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as described before [53, 56]. Briefly, female Sinclair miniswine (5 months age, 
~15 kg) were anesthetized with pentobarbital (30 mg/kg iv), intubated and 
ventilated with a respirator with supplemental oxygen.  A left thoracotomy was 
performed, and the 1st and 2nd diagonal branches of the left anterior descending 
artery were dissected free and permanently occluded with a ligature. The 
ischemic myocardial region became cyanotic in response to the coronary artery 
occlusion. MPCs were injected directly into 5 regions of the peri-infarct border 
zone (BZ) (10 million cells per location; 50 million total diluted in 2 ml saline). 
Injection sites were marked with a stitch to allow identification of the areas for 
histological studies. Animals in the placebo group received 2 ml saline in 5 
injections at similar BZ injection sites. Animals were observed in the open chest 
state for 60 minutes. If ventricular fibrillation occurred, electrical defibrillation was 
performed immediately. The chest was then closed. Animals received standard 
post-operative care including analgesia until they ate normally and became 
active.  
 
MRI Methods MRI was performed on a 1.5 Tesla clinical scanner 
(Siemens Sontata, Siemens Medical Systems, Islen NJ) using a phased-array 4-
channel surface coil and ECG gating.  Animals were anesthetized with 1% 
isoflurane and positioned in a supine position within the scanner. The protocol 
consisted of: 1) localizing scouts to identify the long- and short-axis of the heart, 
2) short- and long-axis cine for the measurement of global cardiac function, and 
3) delayed contrast-enhancement for the assessment of scar size. Steady-state 
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free precession “True-FISP” cine imaging used the following MR parameters: TR 
= 3.1 ms, TE = 1.6 ms, flip angle = 79o, matrix size = 256 x 120, field of view = 
340 mm x 265 mm, slice thickness = 6 mm (4 mm gap between slices) and 16-20 
phases were acquired across the cardiac cycle.  Global function and regional 
wall thickness data were computed from the short-axis cine images using MASS 
(Medis Medical Imaging Systems, Leiden, The Netherlands) for the manual 
segmentation of the endocardial and epicardial surfaces at both end-diastole 
(ED) and end-systole (ED) from base to apex. Short-axis turboFLASH imaging, 
from base to apex, used TR = 16 ms, TE = 4 ms, TI ~ 220 ms, flip angle = 30o, 
matrix size = 256 x 148, field of view = 320 mm x 185 mm, slice thickness = 6 
mm (0 mm gap between slices) and two signal averages.  The appropriate 
inversion time (TI) was chosen to adequately null the signal intensity (SI) of 
normal myocardium.  Infarct size was calculated from the delayed contrast-
enhanced images using MASS to manually segment regions of non-viable tissue.  
Infarct size was calculated as the ratio of the total scar area to the total LV area.  
 
Spatially localized 31P-MR spectroscopy technique Magnetic field 
shimming to improve the magnetic field homogeneity of the heart was achieved 
by the “auto-shim” scheme (Varian Assoc. Inc., CA).  Spatially localized 31P NMR 
spectroscopy was performed using the RAPP-ISIS/FSW method [54, 89-91], 
which is the rotating-frame experiment using adiabatic plane-rotation pulses for 
phase modulation (RAPP)-imaging-selected in vivo spectroscopy (ISIS)/Fourier 
series window (FSW) method. Detailed experiments documenting voxel profiles, 
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voxel volumes and spatial resolution attained by this method have been 
published previously.  In this application of RAPP-ISIS/FSW, the signal origin 
was first restricted to a 12*12 mm two-dimensional column perpendicular to the 
LV wall.  The signal was later localized into three well resolved and five partially 
resolved layers along the column and hence, across the LV wall.  Localization 
along the column was based on B1 phase encoding and employed a 9-term 
Fourier series window as previously describe [54, 89-91].  The phase encoded 
data were used to generate a voxel or a "window" that can be shifted arbitrarily 
by post data acquisition processing along the phase encode direction (in this 
case perpendicular to the surface coil and thus the heart wall); consequently, 
voxels were generated at different distances or "depths" from the outer LV wall.  
However, we normally present five voxels centered about 45°, 60°, 90°, 120°, 
and 135° phase angles as previously described.  There is absolutely no overlap 
between the 135° voxel (corresponding to the subepicardium) and the 45° voxel 
(corresponding to the subendocardium). Whole wall spectra were obtained with 
the image-selected in vivo (ISIS) technique, defining a column 12*12 mm2 
perpendicular to the heart wall.  The calibration of spectroscopic parameters was 
facilitated by placing a polyethylene capillary filled with 15 µl of 3 M/L 
phosphonoacetic acid into the inner diameter of the surface coil. This 
phosphonoacetic acid standard was used only for calculating the 90 degree 
pulse length of the RAPP-ISIS method [54, 89-91]. The position of the voxels 
relative to the coil was set according to the B1 strength at the coil center which 
was experimentally determined in each case by measuring the 90° pulse length 
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for the phosphonoacetic acid standard contained in the reference capillary at the 
coil center. NMR data acquisition was gated to the cardiac and respiratory cycles 
using the cardiac cycle as the master clock to drive both the respirator and the 
spectrometer as previously described [54, 89-91]. The surface coil was 
constructed from a single turn copper wire 25 mm in diameter with each side of 
the coil leads soldered to a 33 pF capacitor. Complete transmural data sets were 
obtained in 10-minute time blocks using a repetition time of 6-7 seconds to allow 
for full relaxation for ATP and inorganic phosphate (Pi) and approximately 95% 
relaxation of the PCr resonance [54, 89-91].  The ratios of PCr to ATP (PCr/ATP) 
were calculated for each transmurally differentiated spectra set as previously 
described [54, 89-91]. All resonance intensities were quantified using integration 
routines provided by the SISCO software.  
 
1H- NMR spectroscopy technique 1H NMR methods have been 
previously reported in detail [54, 92]. In brief, radiofrequency (RF) transmission 
and signal detection were performed with the dually tuned 28 mm diameter 
surface coil. A single-pulse-collection sequence with a frequency selective 
Gaussian excitation pulse (1ms) was used to selectively excite the N-δ proton 
resonance signal of the proximal histidine in deoxymyoglobin (Mb- δ). This 
technique provided sufficient water suppression due to the large chemical shift 
difference between water and Mb- δ (>14 kHz). The NMR signal was optimized 
by adjusting the RF pulse power using the water signal as a reference.  A short 
repetition time (TR = 25 ms) was used due to the short T1 of Mb- δ. Each 
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spectrum was acquired in 5 min (10,000 FIDs).  Although the short T1 of Mb- δ 
and fast acquisition prevent gating to the cardiac cycle, the signal loss due to 
motion is negligible compared to the inherently broad line width of the Mb- δ 
peak. 
 
Surgical preparation for open chest MR spectroscopy study Detailed 
surgical preparations for MRS study are published previously [56, 77, 91]. Briefly, 
animals were anesthetized with pentobarbital (30 mg/kg followed by a 4 mg/kg/hr 
iv), intubated and ventilated with a respirator and supplemental oxygen.  Arterial 
blood gases were maintained within the physiologic range by adjustments of the 
ventilator settings and oxygen flow. 3.0 mm OD heparin-filled polyvinyl chloride 
catheters were inserted into the ascending aorta (Ao) and inferior vena cava (IV). 
A sternotomy was performed, and the heart was suspended in a pericardial 
cradle.  A third heparin-filled catheter was introduced into the LV through the 
apical dimple and secured with a purse string suture.  A 25 mm diameter NMR 
surface coil was sutured onto the anterior wall of the LV adjacent to the infarct 
region.  The 31P and 1H coils were placed in the periscar region 1cm away from 
the infarct site and adjacent to the injection sites. The pericardial cradle was then 
released, and the heart was allowed to assume its normal position in the chest.  
The surface coil leads were connected to a balanced-tuned external circuit and 
the animals positioned within the magnet. Hearts with post infarction LV 
remodeling are very sensitive to alterations of loading conditions of the LV, and 
that subtle differences in LVEDP or LVSP could affect myocardial contractile 
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performance measurements. In order to compensate for insensible fluid loss in 
the open chest studies, we routinely administer saline at rate of 1 ml/min i.v. 
during the entire experimental data acquisition. Ventilation rate, volume and 
inspired oxygen content were adjusted to maintain physiologic values for arterial 
PO2, PCO2 and pH.  Aortic and LV pressures were monitored continuously 
throughout the study.  Hemodynamic measurements were acquired 
simultaneously with the 1H - and 31P- MR spectra.   
 
MR spectroscopy Study protocol and hemodynamic measurements 
Hemodynamic measurements were acquired simultaneously with the NMR 
spectra.  Aortic and LV pressures were measured using pressure transducers 
positioned at mid-chest level [89-91] and recorded on an 8-channel recorder. 
After all the baseline data were obtained, animals received combined 
dobutamine and dopamine infusion (20 μg/kg/min. each) to induce a very high 
cardiac workstate.  After waiting for approximately 5 minutes after the initiation of 
catecholamine infusion, all the spectroscopic and hemodynamic data were again 
measured under the high cardiac workstates.  
 
Tissue preparation   Myocardial drill biopsies from BZ and RZ were taken 
with a pre-cooled biopsy drill and quickly (within 5 seconds) frozen in liquid 
nitrogen [54, 89-91] for subsequent microarray analysis. BZ tissue samples were 
taken at least 3 mm away from the edge of the infarct to avoid contamination with 
scar tissue. The remainder of the LV was sectioned in a bread-loaf manner into 6 
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transverse sections   (~ 10 mm in thickness) from apex to base. Even rings were 
subdivided into 12 circumferential specimens and fixed in zinc fixative (Anatech 
LTD, Battle Creek, MI, USA) for Haematoxylin & Eosin (HE), 
immunofluorescence staining and engraftment evaluation. 
 
Engraftment evaluation   Each of the 12 pieces of cardiac tissue of a 
short axis ring were stained by X-gal (Invitrogen) and embedded in Tissue-Tek 
OCT (Fisher Scientific). Serial cryostat sections (10µm in thickness) were 
obtained from the whole transverse even rings. Engrafted MPCs were identified 
by counting the X-gal-positive nuclei in every 10th serial section of the whole 
transverse ring and then multiplying by 10 to obtain the total number of engrafted 
MPCs per ring. The total number of engrafted MPCs equals two fold x-gal 
staining positive cells in all three even rings. The engraftment rate of transplanted 
MPCs was calculated by dividing the total number of engrafted MPCs by 50 x 106 
(the number of MPCs injected) and multiplying by 100%. 
 
RNA isolation Tissue was placed in TRIzol reagent and homogenized 
using a rotor-stator homogenizer. Homogenates were transferred to a Phase 
Lock Gel (PLG) Heavy tube (Eppendorf), chloroform was added, and the mixture 
was centrifuged. Supernatants were collected, and isopropanol was added to 
precipitate the RNA. The RNA pellet was washed with 80% ethanol, then air-
dried before dissolving in 100 µl of RNase-free H2O. RNA was further purified 
using the RNeasy Mini protocol according to the manufacturer’s directions 
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(Qiagen). The integrity of each RNA sample was validated using an Agilent 
Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA) to measure the ratio of 
28s/18s ribosomal RNA.  
Double-stranded cDNA synthesis Total RNA of 5 µg was used in the 
synthesis of double-stranded cDNA based on Affymetrix protocol with a T7-(dT)24 
primer and 200 U/µl of SuperScript II RT. Second-strand synthesis was 
performed according to the manufacturer’s directions.  
In vitro transcription-synthesis of biotin-labeled cRNA Biotin-labeled 
RNA targets were obtained by using the Enzo BioArray High Yield RNA 
Transcript Labeling Kit via in vitro transcription from bacteriophage T7 RNA 
polymerase promoters according to the manufacturer’s directions (Enzo). The 
cRNA was then fragmented according to the Affymetrix protocol. Quality and 
fragmentation of cRNA was confirmed with gel electrophoresis.  
Target hybridization and probe array wash and stain Hybridization 
cocktail for single standard probe array (Porcine Genome Array, Affymetrix) was 
made by mixing 15 µg of fragmented cRNA with control oligonucleotide B2, 20x 
eukaryotic hybridization controls, herring sperm DNA (10 mg/ml), acetylated BSA 
(50 mg/ml) 2x hybridization buffer, and RNase-free water. Hybridization was 
performed in our Affymetrix Core Facility. 
 Microarray Data analysis  Array data was normalized using GC-RMA 
method using genedata refiner software.  Significance Analysis of Microarrays 
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(SAM) [106] was used to identify probes whose expression was modified 
following stem cell transplantation and showed a fold change greater than 1.7 
and a False Discovery Rate (FDR) of less than 20%. Probes were mapped to 
human genes using the annotation described by Tsai et al [107]. Normalized and 
raw data is available at GEO under the entry GSE14643. 
 
Data analysis   Data were analyzed with repeated measures ANOVA. A 
value of p<0.05 was considered significant. The Bonferroni correction for 
significance level was used to take into account multiple comparisons. All 
statistical analyses were performed in Sigmastat version 3.5 (San Jose, Calif). All 
results are presented as mean ± SD unless otherwise specified. The authors had 
full access to the data and take responsibility for its integrity. All authors have 
read and agree to the manuscript as written. 
 
RESULTS 
Anatomic Data   The anatomic data for the 14 swine is summarized in 
Table 1. MPC transplantation resulted in a significant decrease in left ventricular 
hypertrophy as reflected by a decrease in LVW/BW (2.86±0.12 vs. 3.33±0.16, p< 
0.05) and RVW/BW (1.03±0.08 vs. 1.34±0.10, p<0.05) in the cell treated pigs as 
compared to the saline treated pigs after 4 months.  
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Hemodynamic Data The hemodynamic data at baseline and at increased 
workload are summarized in Table 2. Inotropic stimulation caused a significant 
increase in the heart rate, mean aortic pressure and left ventricular systolic 
pressure and consequently rate pressure product. However, there was no 
significant difference between the swine with cell treatment versus swine without 
cell treatment. 
 
Functional Data   The temporal changes in ejection fraction as measured 
by MRI are depicted in Figure 2. There was no significant difference between the 
two groups at baseline. However, the cell treated group showed a significant 
improvement in ejection fraction which was seen as early as 10 days (43.4±5.1 
% vs. 32.2±5.5 %, p<0.05) after MPC transplantation and persisted up to 4 
months (51.2±4.8 % vs. 35.7±5.0 %, p<0.05). In addition, the MPC treatment 
resulted in reduction of the left ventricular dilatation seen at 4 months after 
myocardial infarction in the saline treated animals, as depicted by significantly 
lower left ventricular end-diastolic (16.9±1.8 ml vs. 22.2±4.8 ml, p<0.05) and left 
ventricular end-systolic volume (8.9±2.3 ml vs. 14.1±2.5 ml, p<0.05) in the MPC 
treated group at 4 month follow-up (Table 3). The initial scar size was similar at 
10 days in both groups; however, there was a significant decrease in scar size in 
the MPC treated animals from 10 days to 4 months (4.6±1.0 % at 4 months vs. 
8.3±1.5 % at 10 days, p<0.05), which was also significantly smaller than the scar 
size in control animals at 4 months (4.6±1.0 % vs. 8.6±2.4 %, p<0.05) (Figure 3). 
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Myocardial high-energy phosphate (HEP) and Pi levels   Myocardial 
HEP and Pi levels are reflected by the PCr/ATP ratios as shown in Table 4. The 
subendocardial and subepicardial myocardial PCr/ATP ratios were significantly 
higher at 4 months in the pigs treated with MPC as compared to those without 
treatment. After increased workload, the PCr/ATP ratio decreased in both groups 
but was still significantly higher in the cell treated pigs. No deoxymyoglobin 
resonance peak was detected in either groups using 1H-MRS, which supports 
our previous findings that the border zone bioenergetic abnormalities in hearts 
with postinfarction LV remodeling is not caused by a persistent myocardial 
ischemia.  
 
Cell engraftment   There was no engraftment of MPC observed at 4 
months after transplantation in any of the cell treated animals.  
 
Microarray analysis As there was no long term engraftment, it was 
postulated that the MPC engraft transiently after transplantation and exert a 
paracrine effect by secretion of factors that may lead to long term gene 
expression changes that may ultimately lead to improved long term outcome. 
Gene expression profiles were collected from seven MPC treated animals and 
six control animals (one animal did not have quality RNA for array analysis) using 
the Affymetrix Porcine Gene chip array containing over 23000 probe sets. SAM 
analysis identified a number of genes that were differentially expressed in the 
heart of the MPC treated animals (Fig.4). There were 41 genes that were down-
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regulated after MPC transplantation and 11 genes that were upregulated (Table 
5). There was down-regulation of several mitochondrial oxidative enzymes 
including 3 different subunits of complex I of the respiratory chain which were 
decreased by 0.59, 0.58 and 0.57 fold, respectively. The levels of ZFP91 (a 
member of the zinc finger family of proteins associated with Ciliary Neurotrophic 
factor) were increased by 3.62 fold. Similarly, Myocyte Enhancer Factor 2a 
(MEF2a) was upregulated by 1.7 fold.  
 
DISCUSSION 
 
The present study demonstrates that MPC transplantation leads to long 
term functional and bioenergetic improvement in a clinically relevant porcine 
model of postinfarction LV remodeling despite no significant engraftment of 
MPCs at 4 months in the heart. Stem cell transplantation resulted in an overall 
improved long term remodeling of the left ventricle following MI with a decrease 
in LV hypertrophy and amelioration of LV dilatation. This was associated with a 
reduction in scar size at 4 months. MPC transplantation also resulted in long term 
differential expression of genes which included a downregulation of mitochondrial 
oxidative enzymes and upregulation of MEF2a and ZFP91.  
 
Long term improvement in ventricular function The present study 
unequivocally demonstrates that MPC transplantation leads to long term 
improvement in ventricular function in a large preclinical animal model. This is an 
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important finding, as clinical studies have shown mixed outcomes after stem cell 
transplantation with some showing benefit [39, 41-42] and some no difference in 
left ventricular ejection fraction [43-44]. In the Bone marrow transfer to enhance 
ST-elevation infarct regeneration (BOOST) study, the treated group showed 
significant short term increase of LV ejection fraction at 6 months, but 
interestingly no difference between the two groups was present at 18 months 
[104]. Similarly, in a rat model of myocardial infarction allogenic MSC treatment 
led to an improvement in left ventricular function 4 weeks after transplantation but 
this improvement was lost at 6 months [37]. In the present study, MPC 
transplantation also mitigated the adverse long term effects of ventricular 
remodeling. This was seen as a reduction in LV hypertrophy (Table 1) and LV 
dilatation (Table 3) in the MPC treated animals. 
 
Myocardial Energetics  Post infarction LV remodeling is associated with 
decreased high energy phosphates, PCr/ATP and expression of several proteins 
crucial to oxidative ATP production and these abnormalities are most severe in 
the borderzone [56]. Our study confirmed these reports and showed that these 
abnormalities are worse in the subendocardial layers and further worsened 
during catecholamine stimulation induced high cardiac workstate (Table 4). 
Previously, we have shown improvement in myocardial energetics 1 month 
following MPC transplantation which is related to reduction in wall stress and 
consequent improvement in the mismatch of energy delivery and demand [77]. In 
the present study, we demonstrate that this improvement in myocardial 
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energetics persist up to 4 months after transplantation (Table 4). In hearts with 
cardiac hypertrophy we have previously reported that myocardial PCr/ATP ratio 
is significantly decreased, which is linearly related to the severity of hypertrophy 
and LV dysfunction, and is independent from a persistent myocardial ischemia 
[89-90, 108-109]. These LVH hearts are also associated with a significant lower 
myocardial total creatine level [89-90, 108, 110], which in principle can cause the 
reduction of the myocardial creatine phosphate level.  In the heart, creatine is not 
synthesized in myocytes, and is up taken by the cell via the creatine transporters 
against a significant concentration gradient [111-112].  The reduction of 
myocardial total creatine content in the LVH hearts was found to be caused by 
the decrease of myocardial creatine transporter [111-112].  In the present study 
we do not have direct evidence on whether the improvement of the PCr/ATP is 
accompanied by the increase of myocardial total creatine content or creatine 
transporter protein expression.   
 
Lack of long term engraftment of MPCs The functional and bioenergetic 
improvement occurred despite no long term engraftment of stem cells in pig 
hearts at 4 months. We have previously shown that there is a very low 
engraftment rate and even lower cardiomyocyte differentiation rate 1 month 
following MPC transplantation [77]. Thus, it seems that there is transient 
engraftment of MPCs in the myocardium which decreases with time and is not 
present at 4 months. This conclusion is supported by other groups which have 
found transient engraftment of MSCs with very little differentiation as early as 3 
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days after transplantation in a mice model of myocardial infarction [81]. In 
contrast, Amado et al have shown that MSC transplantation in a porcine model of 
myocardial infarction led to engraftment of these cells at 2 months which was 
associated with a decrease in scar size and improvement in left ventricular 
function [78]. In a rat model of myocardial infarction, MSC engraftment was seen 
up to 6 months follow-up [37]. These cells expressed muscle specific markers but 
did not fully differentiate into a cardiac phenotype. In another study, intravenous 
injection of human MSC in a mice MI model resulted in functional improvement 
with no engraftment in the heart after 3 weeks [105]. These data support the 
conclusion of the present study that host myocardial structural (Fig 3) and 
genomic expression changes (Table 5) are associated with the observed 
chamber functional improvements (Fig 2). We have also previously shown an 
increase in vascular density in the border zone one month following cell 
transplantation [113].   
 
Effect of cell transplantation on infarct size  Sequential MRI functional 
assessment allowed us to conclude that the infarct size in swine treated with 
MPC decreased from 1 week to 4 month interval, while the scar sizes in swine 
without MPC treatment was maintained throughout the follow-up (Figure 3). This 
reduction in scar size with stem cell treatment has been seen previously in other 
reports [78, 83]. The beneficial effects of MPC transplantation could be related to 
MPC differentiation into cardiomyocytes [11] or mobilization of endogenous 
progenitors to the injury site by paracrine effects [83]. As we did not observe any 
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engraftment of MPCs at 4 months, the functional and bioenergetic improvements 
are likely secondary to paracrine effects that may include sparing of native 
cardiomyocytes from apoptosis. 
 
  Downregulation of mitochondrial oxidative enzymes MPC 
transplantation was associated with downregulation of several different subunits 
of the respiratory chain (Table 5).  The LV dysfunction of failing hearts is 
associated with oxidative stress caused by excess reactive oxygen species 
(ROS) production in the cytoplasm and the electron transport chain of 
mitochondria in myocytes[114].  In the present study, the observed reduction of 
several different subunits of the respiratory chain oxidative enzymes (Table 5) in 
hearts with MPC transplantation may result in reduction of the oxidative stress, 
which could in turn, reduce the myocardial apoptosis that we have observed 
recently using the same cell type for the transplantation and the same animal 
model [113]. 
We have previously reported that LV bulging of the infarct zone was 
accompanied by a significant increase of regional LV wall stress of the infarct 
zone and peri-infarct border zone [56].  This particular increase of regional wall 
stresses and its associated severe bioenergetic abnormality was significantly 
ameliorated by the MPC transplantation [77, 94].  In the present study, we 
reasoned that the decreased bulging of the LV scar area resulted in reduction of 
the regional wall stress and energy demand, which in turn, resulted in the 
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differential expression of several different subunits of the respiratory chain 
enzymes (Table 5).   
 
Increased levels of ZFP91 ZFP91 is a member of the zinc finger family of 
proteins and its expression was increased by 3.62 fold in hearts with MPC 
transplantation.  Apart from the monocistronic transcript originating from this 
locus, a co-transcribed variant composed of ZFP91 and CNTF (Ciliary 
neurotrophic factor) sequence has been identified. CNTF promotes survival and 
decreases apoptosis in neurons and islet cells and has also been shown to 
reverse cardiac hypertrophy in mice [115-116]. 
 
Upregulation of MEF2a The expression of Myocyte Enhancer Factor 2a 
(MEF2a) was increased by 1.7 fold in hearts with MPC transplantation.  MEF2a 
is the predominant MEF2 gene product expressed in postnatal cardiac muscle. 
MEFs play an important role in myogenesis [117]. MEF2a is also important for 
maintaining appropriate mitochondrial content and cyto-architectural integrity in 
the post-natal heart [118]. We postulate that MPC treatment may cause an 
activation of endogenous cardiac stem cells and MEF2a may play a role in their 
differentiation into cardiomyocytes.  
    
In summary, the present study demonstrates that MPC transplantation 
leads to long term functional and bioenergetic improvement in a porcine model of 
postinfarction LV remodeling despite no significant engraftment of stem cells in 
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the heart. MPC transplantation also mitigates the adverse effects of LV 
remodeling as seen by a reduction in LV hypertrophy and LV dilatation. These 
beneficial effects are accompanied by a significant reduction in infarct size. It was 
also shown that MPC transplantation results in differential expression of certain 
genes including mitochondrial oxidative enzymes, ZFP91 and MEF2a which may 
play a role in long term functional improvement after transplantation.   
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FIGURE LEGENDS 
 
Figure 1. Study Design. 
 
Figure 2.  Long term improvement in ventricular function after MPC 
transplantation. A: MPC transplantation leads to an improvement in Ejection 
Fraction as early as 10 days after cell transplantation that persists up to 4 months 
(p<0.05). B: Tabulated form of the Ejection Fraction data from 10 day, 1month, 2 
month, 3 month and 4 month MRI. 
 
Figure 3. Long term reduction in scar size after MPC transplantation.  
 
Figure 4. Heatmap showing all differentially expressed transcripts found using 
affymetrix array analyses of heart tissue with and without exposure to stem 
cells. Expression levels are normalized to the average value of the untreated 
heart tissue and are log transformed. The names associated with each probe 
are the human names obtained from the annotation described in the methods 
section. The probe names can be found in table 5. Normalized and raw data is 
available at GEO under the entry GSE14643. 
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TABLES 
 
Table 1. Anatomic Data obtained 4 months after MI 
 
 
BW 
(kg) 
LVW 
(g) 
RVW 
(g) 
LV/BW 
(g/kg) 
RV/BW 
(g/kg) 
MI (n=7) 16.5±3.7 54.2±5.6 22.0±3.9 3.33±0.16 1.34±0.10 
MI + Cell 
(n=7) 
14.3±2.1 41.0±6.0* 14.5±3.2* 2.86±0.12* 1.03±0.08* 
 
Values are mean±SD; MI, myocardial infarction; n, number of pigs; BW, Body 
weight; LVW, Left ventricular weight; RVW, Right ventricular weight. *, p<0.05 vs. 
MI. 
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Table 2. Hemodynamic data obtained 4 months after MI 
 
 
HR 
(beat/min) 
Mean AoP 
(mmHg) 
LVSP 
(mmHg) 
LVEDP 
(mmHg) 
RPP x 103 
(mmHg.min-1) 
Baseline      
MI 117±19 80±5 100±16 7±1 11.7±2.4 
MI + Cell 110±13 76±8 97±12 5±1 10.6±1.2 
Db + Dp      
MI 150±7* 97±7* 155±16* 8±2 23.3±2.7* 
MI + Cell 142±14* 101±8* 156±21* 5±2 22.1±3.3* 
 
Values are mean±SD; MI, myocardial infarction; DbDp, Dobutamine and 
Dopamine (each 20µg/kg/min intravenous); HR, heart rate; Mean AoP, mean 
aortic pressure; LVSP, left ventricular systolic pressure; LVEDP, left ventricular 
end diastolic pressure; RPP, rate pressure product (HR x LVSP); *, p<0.05 vs. 
Baseline. 
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Table 3. Ventricular volumes 
  
 LVEDV (ml) LVESV (ml) 
 MI MI + Cell MI MI + Cell 
Baseline 16.4±2.4 14.7±2.9 7.9±1.4 6.7±1.4 
10 day 15.8±2.9 14.9±3.1 10.7±3.0 8.4±1.7 
1 month 16.3±2.5 16.7±2.7 10.5±1.9 9.0±1.1 
2 month 17.4±3.5 16.7±1.5 11.5±2.5 9.0±0.2 
3 month 19.6±6.3 16.2±2.5 13.3±5.3 8.2±1.2 
4 month 22.2±4.8 16.9±1.8* 14.1±2.5 8.9±2.3* 
 
Values are mean±SD; MI, myocardial infarction; LVEDV, left ventricular end-
diastolic volume; LVESV, left ventricular end-systolic volume; *, p<0.05 vs. MI. 
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Table 4. Myocardial PCr/ATP ratio 4 months after MI 
 
 Epi Endo 
Baseline   
MI 1.94±0.10 1.65±0.15 
MI + Cell 2.17±0.10* 1.90±0.14* 
Db + Dp   
MI 1.62±0.17† 1.34±0.14† 
MI + Cell 1.91±0.06*† 1.70±0.10*† 
 
Values are mean±SD; MI, myocardial infarction; DbDp, Dobutamine and 
Dopamine (each 20µg/kg/min intravenous); Epi, Subepicardium; Endo, 
Subendocardium;  *, p<0.05 vs. MI; †, p<0.05 vs. Baseline. 
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Table 5. SAM table listing genes that had statistically significant differential 
expression after MPC transplantation 
Gene Name Gene Description GeneCards 
Accession 
Fold 
Change 
 
Downregulated after MPC transplantation 
 
Ssc.26278.1.S1_at importin 13 IPO13 0.55 
Ssc.18764.1.A1_at integrin beta 1 binding protein 3 ITGB1BP3 0.56 
Ssc.3563.1.S1_at PCTAIRE protein kinase 1 PCTK1 0.59 
Ssc.23233.1.S1_a_at Transcribed locus, strongly similar to 
XP_536737.1 PREDICTED: similar to 
mitochondrial carrier protein MGC4399 
[Canis familiaris] 
NP_115691 0.49 
Ssc.16937.1.A1_at tumor protein p53 inducible nuclear 
protein 2 
TP53INP2 0.53 
Ssc.23233.1.S1_a_at glutathione peroxidase 1 GPX1 0.49 
Ssc.16849.1.S1_at follistatin-like 3 (secreted glycoprotein) FSTL3 0.48 
Ssc.2329.1.A1_at glycogen synthase 1 (muscle) GYS1 0.57 
Ssc.9914.1.A1_at creatine kinase, brain CKB 0.52 
Ssc.23508.1.S1_at endoplasmic reticulum-golgi intermediate 
compartment (ERGIC) 1 
Q969X5 0.57 
Ssc.13255.1.A1_at serine/arginine repetitive matrix 2 SRRM2 0.45 
Ssc.11779.1.S1_at folate receptor 1 (Adult) FOLR1 0.52 
Ssc.21553.1.S1_at hepatoma-derived growth factor (high-
mobility group protein 1-like) 
HDGF 0.57 
Ssc.1819.1.S1_at trafficking protein particle complex 1 TRAPPC1 0.58 
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Ssc.22694.1.S1_at NADH dehydrogenase (ubiquinone) 1 
beta subcomplex, 6, 17kDa 
NDUFB6 0.59 
Ssc.5886.1.S1_at mitochondrial ribosomal protein S17 MRPS17 0.56 
Ssc.25389.1.S1_at histidine rich calcium binding protein HRC 0.43 
Ssc.9125.1.S1_at myosin, light chain 9, regulatory MYL9 0.54 
Ssc.12999.1.S1_at glutathione S-transferase pi 1 GSTP1 0.53 
Ssc.12207.1.A1_at Transcribed locus, weakly similar to 
XP_425282.1 PREDICTED: similar to 
MGC68763 protein [Gallus gallus] 
NP_542408 0.57 
Ssc.14392.1.A1_at microseminoprotein, beta- MSMB 0.51 
Ssc.2339.1.S1_at D-dopachrome tautomerase DDT 0.48 
Ssc.2514.1.S1_at Chromosome 11 open reading frame 31 C11orf31 0.46 
Ssc.2447.1.A1_at Chromosome 17 open reading frame 49 Q8IXM2 0.56 
Ssc.12576.1.A1_at Transcribed locus, strongly similar to 
XP_548156.1 PREDICTED: similar to 
CG3420-PA [Canis familiaris] 
       - 0.58 
Ssc.23542.1.A1_at NADH dehydrogenase (ubiquinone) 1 
beta subcomplex, 11, 17.3kDa 
NDUFB11 0.58 
Ssc.26100.1.S1_at NADH dehydrogenase (ubiquinone) 1 
beta subcomplex, 7, 18kDa 
NDUFB7 0.57 
Ssc.27967.1.A1_at polymerase (RNA) II (DNA directed) 
polypeptide L, 7.6kDa 
POLR2L 0.48 
Ssc.21753.1.S1_at Ubiquitously-expressed transcript UXT 0.52 
Ssc.3197.1.S1_at Transcribed locus, moderately similar to 
XP_533944.1 PREDICTED: similar to 
QIL1 [Canis familiaris] 
NP_991330 0.51 
Ssc.2261.1.S1_at APC11 anaphase promoting complex ANAPC11 0.56 
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subunit 11 homolog (yeast) 
Ssc.24290.1.S1_at biogenesis of lysosomal organelles 
complex-1, subunit 1 
BLOC1S1 0.53 
Ssc.3675.1.A1_at calmodulin 2 (phosphorylase kinase, 
delta) 
CALM2 0.54 
Ssc.21117.1.A1_at Transcribed locus, strongly similar to 
XP_213214.2 PREDICTED: similar to 
mitochondria-associated granulocyte 
macrophage CSF signaling molecule 
[Rattus norvegicus] 
MAGM_HUM
AN 
0.55 
Ssc.7580.1.A1_at chromosome 17 open reading frame 61 Q8N2U0 0.56 
Ssc.19954.1.S1_at Transcribed locus, moderately similar to 
NP_060694.1 hypothetical protein 
FLJ10803 [Homo sapiens] 
      - 0.57 
Ssc.17618.1.S1_at Clone Clu_6860.scr.msk.p1.Contig4, 
mRNA sequence 
Q8NAX4 0.56 
Ssc.19477.1.A1_at trafficking protein particle complex 5 TRAPPC5 0.58 
Ssc.5035.1.S1_at mitochondrial ribosomal protein S18A MRPS18A 0.56 
Ssc.19928.1.S1_a_at deoxyuridine triphosphatase DUT 0.54 
Ssc.14361.1.A1_at olfactomedin 1 OLFM1 0.56 
 
Upregulated after MPC transplantation 
 
Ssc.24458.1.A1_at KIAA1429 Q69YN4 1.83 
Ssc.10473.1.A1_at zinc finger protein 91 homolog (mouse) ZFP91 3.62 
Ssc.8896.1.A1_at GDP-mannose 4,6-dehydratase GMDS 1.76 
Ssc.21898.1.S1_at ERO1-like (S. cerevisiae) ERO1L 1.86 
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Ssc.25201.1.A1_at regulating synaptic membrane 
exocytosis 2 
RIMS2 2.09 
Ssc.29206.1.A1_at chromosome 19 open reading frame 2 C19orf2 2.56 
Ssc.13545.1.A1_at chromosome 21 open reading frame 66 C21orf66 2.15 
Ssc.18307.1.A1_at RNA binding motif protein 25 RBM25 2.38 
Ssc.12654.2.A1_at myocyte enhancer factor 2A MEF2A 1.70 
Ssc.8247.1.A1_at opioid binding protein/cell adhesion 
molecule-like 
OPCML 1.71 
Ssc.27217.2.A1_at zinc finger protein 354A ZNF354A 1.84 
 
SAM, Significance Analysis of Microarrays. Normalized and raw data is available 
at GEO under the entry GSE14643. 
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CHAPTER 5: LONG TERM PRESERVATION OF MYOCARDIAL ENERGETICS 
IN CHRONICALLY HIBERNATING MYOCARDIUM 
 
Mohammad Nurulqadr Jameel , Qinglu Li , Abdul Mansoor, Qiang Xiong, 
Cory Swingen, Jianyi Zhang. 
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We previously reported that the myocardial energetic state, as defined by 
PCr/ATP, was preserved at baseline in a swine model of chronic myocardial 
ischemia with a mild reduction of myocardial blood flow (MBF) 10 weeks after 
placement of an external constrictor on the LAD. It remains to be seen whether 
this stable energetic state is maintained at a longer term follow-up.  Hibernating 
Myocardium (HB) was created in mini-pigs (n=7) by the placement of an external 
constrictor (1.25 mm i.d) on the LAD. Function was assessed with MRI at regular 
intervals for 6 months. At 6 months, myocardial energetics in the HB was 
assessed by 31P-MRS and myocardial oxygenation was examined from the 
deoxymyoglobin signal (Mb-δ)  using 1H-MRS during baseline (BL), coronary 
vasodilation with adenosine (AD) and high cardiac work load (HWL) with 
dopamine and dobutamine (DpDb). MBF was measured with radiolabeled 
microspheres. At BL, systolic thickening fraction was significantly lower in the HB 
as compared to remote region (34.4±9.4 vs 50.1±10.7, p=0.006). This was 
associated with a decreased MBF in the HB as compared to remote region 
(0.73±0.08 ml/min.g vs 0.97±0.07 ml/min.g, p=0.03). The HB PCr/ATP ratio at BL 
was normal. DpDb resulted in a significant increase in RPP, which caused a 2 
fold increase in MBF in the HB and a 3 fold increase in the remote region. The 
systolic thickening fraction increased with DpDb that was significantly higher in 
the remote region than HB (p<0.05). The HWL was associated with a significant 
reduction in the HB PCr/ATP ratio (p<0.02) but this response was similar to 
normal myocardium. Thus, HB has stable baseline myocardial energetics despite 
a reduction in MBF and regional LV function. More importantly, HB has a 
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reduced contractile reserve but has a similar energetic response to high cardiac 
workload as normal myocardium. 
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Introduction 
 
In clinical practice, hibernating myocardium refers to areas of regional 
dysfunction, decreased blood flow and absence of scar in patients with coronary 
artery disease which are thought to recover after revascularization [63-65]. 
Hibernating myocardium is characterized by a balance between matched 
reductions in myocardial blood flow and function [119-120]. The acute perfusion 
contraction matching in short term hibernation is maintained up to 90 minutes 
after the initiation of moderate ischemia and is not sustained over several hours 
[119-120]. In animal models, chronic hibernating myocardium can be created by 
constriction of a proximal coronary artery that leads to progressive reduction in 
myocardial blood flow and regional dysfunction [66-76]. Perfusion contraction 
matching in this model probably develops from a single or repetitive bouts of 
stress induced ischemia and reperfusion in the presence of severe coronary 
stenosis [119-120]. Thus, there is a temporal progression from chronic stunning 
to hibernation in which the reduced resting blood flow is the result rather than the 
cause of chronic contractile dysfunction [66-76]. Decreased myocardial oxygen 
consumption has been observed in hibernating myocardium at rest and during 
increased myocardial oxygen demand which contrasts with findings in short term 
hibernating myocardium [72, 121]. Chronic hibernating myocardium 
demonstrates alteration in metabolism with an increase in glucose uptake and 
glycogen storage [69, 73-74]. The energetic state in the hibernating myocardium 
has been studied previously with diverse results [75, 122-124].  
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Our laboratory specializes in studying myocardial energetic states in vivo with 
NMR spectroscopy. Energetic state refers to delta G which is the free energy of 
ATP hydrolysis [125].  ∆GATP (kJ/mol) = ∆G° − RT ln ([ATP]/[ADP][Pi]), where 
∆Go (− 30.5 kJ/mol) is the value of ∆GATP under standard conditions of molarity, 
temperature, pH, and [Mg2+], R is the gas constant (8.3 J/mol K), and T is 
temperature (Kelvin). Delta G  is linearly related to the myocardial PCr/ATP [125]. 
The set point of the driving force and the efficiency of mitochondria ATP 
production (mtOXPHOS) are reflected by the myocardial PCr/ATP (delta G).  In 
chronic heart failure or acute myocardial ischemia, the myocardial energetic state 
is decreased that is reflected by a decrease in PCr/ATP [50-51, 53, 56, 90, 126-
127]. In a short term follow-up of animals with chronic hibernation, we showed 
that despite a reduction in myocardial blood flow and regional function, the 
hibernating myocardium has well preserved myocardial energetics [75].  
 
The aim of the present study is three fold. Firstly, we aim to create a model of 
chronic hibernation in mini-pigs to allow us to study the energetic state in chronic 
hibernating myocardium up to 6 months. Our second objective is to determine 
sequential measurements of myocardial blood flow in this model with MR 
imaging to assess for sequential changes in blood flow and its correlation with 
regional function. Thirdly, and most importantly, we hypothesize that chronic 
hibernating myocardium will maintain a stable energetic state for up to 6 months 
at baseline and with increased work load.  
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Methods 
 
All experiments were performed in accordance with the animal use guidelines of 
the University of Minnesota, and the experimental protocol was approved by the 
University of Minnesota Institutional Animal Care and Use Committee (IACUC). 
The investigation conformed to the “Guide for the care and use of laboratory 
animals” published by the National Institutes of Health (NIH publication No 85-23, 
revised 1985). 
Animal Preparation  
Sinclair Miniswines (Sinclair Research Center, MO) were used for this study. 
Sinclair pigs are research purpose bread, and grow very slowly which allowed us 
to follow these animals for long term. A chronic hibernation myocardium model 
was created in seven mini-pigs. Briefly, female Sinclair miniswine (5 months age) 
were anesthetized with pentobarbital (30 mg/kg iv), intubated and ventilated with 
a respirator with supplemental oxygen.  A left thoracotomy was performed. The 
left anterior descending coronary artery (LAD) was dissected free, and a C-
shaped titanium occluder (3 mm in length and 1.25 mm in internal diameter) was 
secured around the proximal vessel and gently closed with suture. In all animals, 
the pericardium and chest were closed in layers. Animals received standard post-
operative care including analgesia until they ate normally and became active.  
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Regional Function Measurements  
Ventricular function was assessed using MRI before surgery and then at 2 
weeks, 1 month, 4 month and 6 month after instrumentation. MRI was performed 
on a 1.5 Tesla clinical scanner (Siemens Sontata, Siemens Medical Systems, 
Islen NJ) using a phased-array 4-channel surface coil and ECG gating as 
previously described in detail [50]. Animals were anesthetized with 1% isoflurane 
and positioned in a supine position within the scanner. The protocol consisted of: 
1) localizing scouts to identify the long- and short-axis of the heart, 2) short- and 
long-axis cine for the measurement of global cardiac function, and 3) delayed 
contrast-enhancement for the assessment of scar size. Steady-state free 
precession “True-FISP” cine imaging used the following MR parameters: TR = 
3.1 ms, TE = 1.6 ms, flip angle = 79o, matrix size = 256 x 120, field of view = 340 
mm x 265 mm, slice thickness = 6 mm (4 mm gap between slices) and 16-20 
phases were acquired across the cardiac cycle.  Global function and regional 
wall thickness data were computed from the short-axis cine images using MASS 
(Medis Medical Imaging Systems, Leiden, The Netherlands) for the manual 
segmentation of the endocardial and epicardial surfaces at both end-diastole 
(ED) and end-systole (ED) from base to apex. End-diastole and end-systole were 
determined by evaluating the largest and smallest ventricular volumes during a 
cycle. Short-axis turboFLASH imaging, from base to apex, used TR = 16 ms, TE 
= 4 ms, TI ~ 220 ms, flip angle = 30o, matrix size = 256 x 148, field of view = 320 
mm x 185 mm, slice thickness = 6 mm (0 mm gap between slices) and two signal 
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averages.  The appropriate inversion time (TI) was chosen to adequately null the 
signal intensity (SI) of normal myocardium.  The LV papillary muscles, as well as 
the LV short and long axis were used as landmarkers for the cardiac MRI and 
indentifying the LAD region. The spatial resolution of the MRI measurements is 
very high (approximately 1-2 mm).  
 
Myocardial Blood Flow with First Pass Perfusion MRI 
Sequential myocardial blood flow measurements were obtained before surgery 
and then at 2 weeks, 1 month, 4 month and 6 month after instrumentation. 
Perfusion imaging was performed with a bolus injection of 0.025 mmol/kg of 
gadolinium (Gd)-diethylenetriamine pentaacetic acid (DTPA) at 5 ml/s through a 
power injector. We chose this dose to be in the linear range of Gd-DTPA 
concentration and signal intensity (SI) within the blood pool. A saturation-
recovery gradient echo imaging with an echo-train readout was used. The field of 
view was 30 cm2, matrix was 1.4 × 1.4 mm, and short-axis slice thickness was 8 
mm, the repetition time = 6.3 ms, echo time = 1.3 ms, flip angle = 20°, and the 
echo train = 4. During bolus transit, 3 to 4 short-axis images were acquired per 1 
R-R interval gated to the electrocardiographic signal of the animal over 40 to 60 
heart beats. 
 
Perfusion images were analyzed offline with an interactive data language-based 
software program (Cine Tool GEMS, Milwaukee, Wisconsin). Time intensity 
curves (TIC) were generated from both the left ventricular blood pool to obtain 
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the arterial input function to the coronary circulation and from the myocardial 
tissue. These were 1.0 to 1.5 cm2 in area to coincide with volume of the 
pathologic sections. The concept of deconvolution of arterial input function with a 
shaped function to fit the tissue enhancement curve was employed as first 
described by L. Axel, Tissue mean transit time from dynamic computed 
tomography by a simple deconvolution technique [128], and adapted to CMR 
[129]. A Fermi function is used to deconvolve the arterial input function to fit the 
myocardial TIC in a region of interest. Perfusion scans were acquired for 40 R-R 
intervals, and the entire myocardial TIC was used to generate the fit with the 
arterial input function. The resultant amplitude of the Fermi function after the fit 
reflects absolute MBF [128-129]. Signal noise was calculated for each study by 
measuring the SD of the mean SI to a region of interest outside the chest cavity. 
This was done to separate the impact of noise from tissue SI. The contrast 
enhancement ratio was calculated by: (peak enhancement − pre-contrast) SI/pre-
contrast SI, during FP perfusion. 
 
Myocardial blood flow measurement with microspheres 
Myocardial blood flow was measured using radionuclide labeled microspheres 15 
µm in diameter labeled with 4 different radioisotopes (51Cr, 85Sr, 95Nb and 46Sc) 
during the terminal NMR study at 6 month follow-up.  Microsphere suspension 
containing 2x106
 
microspheres was injected through the left atrial catheter while 
a reference sample of arterial blood was withdrawn from the aortic catheter at a 
rate 15 ml/min beginning 5 seconds before the microsphere injection and 
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continuing for 120 seconds.  Radioactivity in the myocardial and blood reference 
specimens was determined using a gamma spectrometer (Packard Instrument 
Company, Downers Grove, IL) at window settings chosen for the combination of 
radioisotopes used during the study.  Activity corrected for overlap between 
isotopes and for background was used to compute blood flow as ml/g of 
myocardium/minute. 
 
Surgical preparation for open chest MR spectroscopy study  
Detailed surgical preparations for MRS study are published previously [56, 77, 
91]. Briefly, animals were anesthetized with pentobarbital (30 mg/kg followed by 
a 4 mg/kg/hr iv), intubated and ventilated with a respirator and supplemental 
oxygen.  Arterial blood gases were maintained within the physiologic range by 
adjustments of the ventilator settings and oxygen flow. 3.0 mm OD heparin-filled 
polyvinyl chloride catheters were inserted into the ascending aorta (Ao) and 
inferior vena cava (IV). A sternotomy was performed, and the heart was 
suspended in a pericardial cradle.  A third heparin-filled catheter was introduced 
into the LV through the apical dimple and secured with a purse string suture.  A 
25 mm diameter NMR surface coil was sutured onto the anterior wall of the LV.  
The pericardial cradle was then released, and the heart was allowed to assume 
its normal position in the chest.  The surface coil leads were connected to a 
balanced-tuned external circuit and the animals positioned within the magnet. In 
order to compensate for insensible fluid loss in the open chest studies, we 
routinely administer saline at rate of 1 ml/min i.v. during the entire experimental 
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data acquisition. Ventilation rate, volume and inspired oxygen content were 
adjusted to maintain physiologic values for arterial PO2, PCO2 and pH.  Aortic 
and LV pressures were monitored continuously throughout the study.  
Hemodynamic measurements were acquired simultaneously with the 1H - and 
31P- MR spectra.   
 
MR spectroscopy Study protocol and hemodynamic measurements  
Hemodynamic measurements were acquired simultaneously with the NMR 
spectra.  Aortic and LV pressures were measured using pressure transducers 
positioned at mid-chest level [89-91] and recorded on an 8-channel recorder. 
After all the baseline data were obtained, animals received adenosine to cause 
maximal vasodilation and the measurements were repeated. This was following 
by combined dobutamine and dopamine infusion (20 μg/kg/min. each) to induce 
a very high cardiac workstate.  After waiting for approximately 5 minutes after the 
initiation of catecholamine infusion, all the spectroscopic and hemodynamic data 
were again measured under the high cardiac workstates.  
 
31P-NMR Spectroscopy Technique  
31P-NMR spectroscopy has been used to study myocardial energetics [130]. 
NMR spectroscopy was performed at 6 month follow-up in a 4.7T magnet. 
Magnetic field shimming to improve the magnetic field homogeneity of the heart 
was achieved by the “auto-shim” scheme (Varian Assoc. Inc., CA).  Spatially 
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localized 31P NMR spectroscopy was performed using the RAPP-ISIS/FSW 
method [54, 89-91], which is the rotating-frame experiment using adiabatic plane-
rotation pulses for phase modulation (RAPP)-imaging-selected in vivo 
spectroscopy (ISIS)/Fourier series window (FSW) method. Detailed experiments 
documenting voxel profiles, voxel volumes and spatial resolution attained by this 
method have been published previously.  In this application of RAPP-ISIS/FSW, 
the signal origin was first restricted to a 12*12 mm two-dimensional column 
perpendicular to the LV wall.  The signal was later localized into three well 
resolved and five partially resolved layers along the column and hence, across 
the LV wall.  Localization along the column was based on B1 phase encoding and 
employed a 9-term Fourier series window as previously describe [54, 89-91].  
The phase encoded data were used to generate a voxel or a "window" that can 
be shifted arbitrarily by post data acquisition processing along the phase encode 
direction (in this case perpendicular to the surface coil and thus the heart wall); 
consequently, voxels were generated at different distances or "depths" from the 
outer LV wall.  However, we normally present five voxels centered about 45°, 
60°, 90°, 120°, and 135° phase angles as previously described.  There is 
absolutely no overlap between the 135° voxel (corresponding to the 
subepicardium) and the 45° voxel (corresponding to the subendocardium). Whole 
wall spectra were obtained with the image-selected in vivo (ISIS) technique, 
defining a column 12*12 mm2 perpendicular to the heart wall.  The calibration of 
spectroscopic parameters was facilitated by placing a polyethylene capillary filled 
with 15 µl of 3 M/L phosphonoacetic acid into the inner diameter of the surface 
 coil. This phosphonoacetic acid standard was used only for calculating the 90 
degree pulse length of the RAPP-ISIS method [54, 89-91]. The position of the 
voxels relative to the coil was set according to the B1 strength at the coil center 
which was experimentally determined in each case by measuring the 90° pulse 
length for the phosphonoacetic acid standard contained in the reference capillary 
at the coil center. NMR data acquisition was gated to the cardiac and respiratory 
cycles using the cardiac cycle as the master clock to drive both the respirator and 
the spectrometer as previously described [54, 89-91]. The surface coil was 
constructed from a single turn copper wire 25 mm in diameter with each side of 
the coil leads soldered to a 33 pF capacitor. Complete transmural data sets were 
obtained in 10-minute time blocks using a repetition time of 6-7 seconds to allow 
for full relaxation for ATP and inorganic phosphate (Pi) and approximately 95% 
relaxation of the PCr resonance [54, 89-91].  The ratios of PCr to ATP (PCr/ATP) 
were calculated for each transmurally differentiated spectra set as previously 
described [54, 89-91]. All resonance intensities were quantified using integration 
routines provided by the SISCO software.  
 
CK kinetics measurement with 31P MRS saturation transfer  
A double-tuned (200 MHz for 1H and 81 MHz for 31P) surface coil (diameter, 
28 mm) was used for RF transmission and signal detection. A chemical shift 
selective (CHESS) pulse sequence was employed to saturate the ATP  
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 resonance [131]; this sequence consisted of a 90° Sinc RF excitation pulse 
followed by a short half-sine gradient pulse in all three orthogonal axes to 
enhance the dephasing of transverse magnetization. This CHESS sequence was 
applied repetitively to ensure complete saturation of the ATP  resonance. The 
repetition time for signal acquisition of 12 s provided fully relaxed ATP  and PCr 
resonances. Control spectra were acquired with the saturation carrier frequency 
setting on the opposite side of the PCr resonance with a frequency difference 
identical to that between PCr and ATP . The relative change of the PCr 
resonance intensity between the saturated and control spectra is proportional to 
the forward rate constant (kf) in the exchange reaction between PCr and ATP. All 
spectra were recorded with a spectral width of 6,000 Hz. The forward rate of CK 
(kf: PCr  ATP ) and the intrinsic longitudinal relaxation time for PCr (T1) were 
calculated based on the two-site chemical exchange model as follows: kf = (
M/M0)/T  and 1/T1 = 1/T   kf, where kf and T1 represent the pseudo first-order 
rate constant and the intrinsic longitudinal relaxation time of PCr, respectively; 
M = M0  Minfinite, where M0 and Minfinite represent the magnetization at saturation 
zero and infinite times, respectively; and T  is the time constant that describes 
the integral of PCr magnetization decay as the time of saturation of ATP  
increased from 0 to infinity. The CK forward flux rate (Fluxf) was calculated as the 
product of kf and the myocardial PCr concentration (Fluxf = kf [PCr]). Each set of 
spectra for saturation transfer measurements required ~6.2 min. 
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1H- NMR spectroscopy technique 
 
 1H NMR spectroscopy was performed on 4.7T and the methods have been 
previously reported in detail [54, 92]. In brief, radiofrequency (RF) transmission 
and signal detection were performed with the dually tuned 28 mm diameter 
surface coil. A single-pulse-collection sequence with a frequency selective 
Gaussian excitation pulse (1ms) was used to selectively excite the N-δ proton 
resonance signal of the proximal histidine in deoxymyoglobin (Mb- δ). This 
technique provided sufficient water suppression due to the large chemical shift 
difference between water and Mb- δ (>14 kHz). The NMR signal was optimized 
by adjusting the RF pulse power using the water signal as a reference.  A short 
repetition time (TR = 25 ms) was used due to the short T1 of Mb- δ. Each 
spectrum was acquired in 5 min (10,000 FIDs).  Although the short T1 of Mb- δ 
and fast acquisition prevent gating to the cardiac cycle, the signal loss due to 
motion is negligible compared to the inherently broad line width of the Mb- δ 
peak. 
 
Statistics  
 
Statistical analysis was performed using 2-way ANOVA (hibernating vs. remote, 
baseline vs. time) with post-hoc analysis. For comparison between the two 
treatment groups, the conventional significance level of type I error (P < 0.05) 
was used. The Bonferroni correction for the significance level was used to take 
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into account multiple comparisons. All values are expressed as mean ± standard 
deviation (SD). All statistical analyses were performed in Sigmastat version 3.5 
(San Jose, CA).  
 
Results 
 
Resting Myocardial Blood Flow in Hibernating Myocardium 
 
A titanium c-shaped occluder device with an internal diameter of 1.25mm was 
placed over the proximal LAD. MR Angiography was performed to determine the 
progression in severity of stenosis over time. It showed that at 1 month there is 
approximately 75% stenosis and it progresses to >90% stenosis of the proximal 
LAD at 4 months but was not completely occluded. There was a gradual decline 
of myocardial blood flow (MBF) in the anterior region of the heart. Resting MBF 
data obtained with Perfusion MRI  is summarized in Fig. 1. There was a trend 
towards decreased MBF in the LAD territory as compared to Remote region at 1 
month (1.08±0.06 ml.min-1.g-1 vs 1.32±0.05 ml.min-1.g-1, p=0.06). At 4 month, the 
LAD region had significantly decreased MBF than the Remote region (0.78±0.05 
ml.min-1.g-1 vs 1.22±0.04 ml.min-1.g-1, p=0.008) which persisted up to the 6 month 
follow-up (0.75±0.04 ml.min-1.g-1 vs 1.14±0.08 ml.min-1.g-1, p=0.01). 
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Coronary Flow Reserve in Hibernating Myocardium 
 
During the final terminal study at 6 months, MBF was measured by injection of 
microspheres at baseline and after intravenous adenosine administration (Fig. 2). 
The baseline MBF data correlated with the perfusion MRI data obtained at 
baseline at 6 months. This demonstrates that at baseline, hibernating 
myocardium has decreased MBF as compared to remote myocardium 
(0.73±0.08 ml.min-1.g-1 vs 0.97±0.07 ml.min-1.g-1, p < 0.05). Moreover, 
subendocardial blood flow (0.62±0.06 ml.min-1.g-1 vs 1.20±0.06 ml.min-1.g-1, p < 
0.05) showed the most dramatic decrease in the hibernating myocardium with 
subsequent decrease in the endo/epi ratio. After adenosine vasodilation, MBF 
was critically impaired in the LAD region and only increased minimally (0.73±0.08 
ml.min-1.g-1 vs 1.04±0.12 ml.min-1.g-1, p=NS) as compared to the more than 3 fold 
increase in MBF in the remote region (0.97±0.07 ml.min-1.g-1 vs 3.22±0.25 
ml.min-1.g-1, p=0.0007) (Fig. 2). Coronary Flow Reserve (CFR= MBF after 
maximal hyperemia with adenosine/MBF at rest) was calculated and was 
significantly lower in HB as compared to remote region (1.38±0.12 in HB vs 
3.36±0.14 in remote myocardium, p<0.05).  
 
Ventricular Function in Hibernating Myocardium 
 
The weights of the animal were 20±3 kg at 6 months. Serial measurements of 
ventricular volumes, ventricular mass and ejection fraction have been 
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summarized in Table 1. These demonstrate that the global left ventricular 
function was normal in all the animals throughout the follow-up period. There was 
no evidence of myocardial infarction by delayed enhanced MRI. None of the 
animals developed clinical heart failure and LVEDP was normal in all animals at 
6 months (2.8±3.3mmHg) and none of the animals had LVEDP greater than 10. 
There were two animals that died from sudden cardiac death and thus mortality 
was 22% over a period of 6 months. Regional ventricular function is summarized 
in Fig. 3. Systolic Thickening Fraction was significantly decreased in the LAD 
region as compared to Remote region at 1 month (36.2±7.0% vs 52.4±7.2%, 
p=0.04). This persisted at 4 month (34.2±7.8% vs 52.8±8.2%, p=0.02) and 6 
month (34.4±7.2% vs 50.1±7.6%, p=0.02). 
 
Response to Increased Cardiac Workload in Hibernating Myocardium 
 
Even though that the resting myocardial blood flow and function in the 
hibernating myocardium was decreased, all the animals had an appropriate 
hemodynamic response to inotropic stimulation. Intravenous administration of 
dopamine and dobutamine resulted in a significant increase in heart rate 
(101.6±14.9 vs 153±32.7, p=0.019), left ventricular systolic pressure (103.8±16.5 
mmHg vs 160±40.5 mmHg, p=0.04) and consequently Rate Pressure Product 
(10.6±2.3 x 103 vs 25.0±10.8 x 103, p=0.04) (Table 2). This increase in workload 
was associated with only a 53.4% increase in MBF in the hibernating 
myocardium as compared to a 222% increase in MBF in the remote myocardium 
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(Fig 4). The thickening fraction was similar at baseline in the hibernating 
myocardium and remote myocardium. Thickening fraction increased significantly 
in the remote area after inotropic stimulation as compared to baseline (p<0.05). 
Moreover, thickening fraction was significantly higher in the remote area as 
compared to hibernating myocardium after inotropic stimulation (84.1±10.4% vs 
42.2±8.6%, p=0.006). However, there was no significant difference between the 
thickening fraction at baseline and increased workload in the hibernating 
myocardium.  
 
Myocardial Energetics in Hibernating Myocardium 
 
Transmural High Energy Phosphate (HEP) measurements in the hibernating 
myocardium are summarized in Table 3. In addition, these have been compared 
to normal minipig controls and historical normal controls [54, 131]. This shows 
that the hibernating myocardium has normal energetic state at baseline as 
reflected by the PCr/ATP ratio. The subepicardial, subendocardial and full 
thickness PCr/ATP ratios in the hibernating myocardium are 2.33±0.09, 
1.88±0.06 and 2.25±0.21 respectively which are similar to normal minipigs and 
historical pig controls. As shown, there is a significant decrease in PCr/ATP ratio 
with inotropic stimulation (1.84±0.23 vs 2.25±0.21, p=0.03) but this decrease is 
similar to what is observed in normal myocardium at a similar work-load [54]. The 
increased workload was associated with a 20.4±0.12% decrease in ATP 
production rate via Creatine Kinase which is again similar to previous 
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observations in normal pigs at increased workload [54]. Transmural myocardial 
oxygenation, by in vivo H1-MRS myoglobin saturation levels, demonstrated no 
myoglobin desaturation in the hibernating myocardium at rest or with increased 
cardiac workload. Thus, myocardial ischemia is not observed in hibernating 
myocardium despite a depression in myocardial blood flow and reduction in wall 
thickening. 
 
The CK forward flux rate (Fluxf) was calculated as the product of kf and the 
myocardial PCr concentration (Fluxf = kf [PCr]), where [PCr]=[ATP] x PCr/ATP. 
ATP concentration in hibernating myocardium has been previously reported by 
Canty et al as 20.1±1.0 µmol/g dry weight [123]. Under baseline conditions in our 
study, the PCr/ATP ratio and kf were 2.25±0.21 and 0.40±0.04 sec-1. Thus, Fluxf  
was calculated as 18.1±2.1 µmol g-1 sec-1. This value is similar to what has been 
reported for normal pigs (20.3±2.4 µmol g-1 sec-1) [53].  
 
Discussion 
 
This study describes the longest follow up of experimental chronic hibernation in 
a pre-clinical large animal model. It utilized cardiac MRI to demonstrate the 
temporal changes in blood flow and regional function in hibernating myocardium 
to elucidate the exact timing of development of the phenomenon of hibernating 
myocardium in these animals. More importantly, it reveals that the myocardial 
energetic state as reflected by PCr/ATP ratio is normal under baseline conditions  
 115 
up to 6 months in hibernating myocardium despite a reduction in perfusion 
reserve and regional function. Furthermore, the decrease in PCr/ATP ratio with 
increased workload in hibernating myocardium is similar to normal myocardium. 
 
Creation of Hibernating Myocardium animal model 
 
Our previous study of myocardial energetics in hibernating myocardium was 
limited to a follow-up period of 10 weeks because of the large size of the farm 
pigs which were not able to fit in the bore size of the magnet used for Magnetic 
Resonance studies [75]. Thus, in the current study we used Mini-swine which 
grow at a slower rate and thus do not attain a large size despite a longer follow-
up period. This allowed us to follow the function and blood flow in the hibernating 
myocardium up to six months and study the myocardial energetics in the 
hibernating myocardium at this longer follow-up. A titanium c-shaped occluder 
device with an internal diameter of 1.25mm was placed over the proximal LAD, 
which is smaller than the 1.4mm size used in the farm pig study [75]. MR 
Angiography was performed to determine the progression in severity of stenosis 
over time. It showed that at 1 month there is approximately 75% stenosis and it 
progresses to >90% stenosis of the proximal LAD at 4 month but it was not 
completely occluded. It has been shown previously that hibernating myocardium 
develops regardless of whether the chronic stenosis was eventually totally 
occluded or remained patent; however, the inotropic reserve that was recruited 
by epinephrine depended on coronary reserve and was greater with a patent 
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artery in that study [132].  There was no evidence of myocardial infarction by late 
enhanced gadolinium MR imaging and on gross visualization at the time of 
sacrifice at 6 months. Focal myocardial damage exceeding 5% of myocardium 
within the region of interest seems to be necessary for detection of LGE in vivo in 
an experimental model of coronary microembolization [133]. Thus, smaller areas 
of fibrosis cannot be excluded in the present study. 
 
Temporal changes in Myocardial Blood Flow in Hibernating Myocardium 
 
A unique feature of our study was the ability to examine the serial changes of 
myocardial blood flow non-invasively using quantitative MR perfusion imaging 
techniques. This showed that the myocardial blood flow in the hibernating 
myocardium started to decline at 1 month. Thus, the absolute MBF in the 
hibernating myocardium was significantly lower than the remote region at 4 and 6 
month follow up. CMR perfusion imaging has been used to demonstrate 
decreased resting MBF in patients with CAD and regional LV dysfunction [134]. 
There is excellent correlation between microsphere and MRI myocardial blood 
flow measures. We have previously shown that hypoperfused regions, identified 
with microspheres, on the first-pass MR images displayed significantly decreased 
signal intensities compared with normally perfused myocardium (P < .0007) 
[135]. Moreover, flow estimates by first pass MR imaging averaged 1.2 mL/min/g 
+/- 0.5 (n = 29), compared with 1.3 mL/min/g +/- 0.3 obtained with tracer 
microspheres in the same tissue specimens at the same time. In the present 
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study, MBF in control myocardium at 6 months is 1.14±0.08 and 0.97±0.07 by 
MR perfusion imaging and microspheres respectively, while in hibernating 
myocardium at 6 months the MBF is 0.75±0.04 and 0.73±0.08. We believe it is 
the first time sequential MBF measurements have been obtained in an animal 
model of chronic hibernating myocardium. Transmural MBF measurements at 6 
months using microsphere also showed that the subendocardial layer had the 
most significant decrease in MBF with a subsequent decrease in the endo/epi 
MBF ratio. The myocardial perfusion reserve was also markedly diminished in 
the hibernating myocardium as shown previously [72]. 
 
It is interesting to note that systolic thickening fraction was maintained in 
hibernating myocardium between 1 and 6 months (Figure 3),  whereas the  MBF 
gradually continued to decrease by an additional 25% (Figure 1), which suggests 
that the hibernating myocardium is becoming more efficient between 1 and 6 
months (maintaining the same function while being provided less blood flow). 
Assuming the mitochondrial OXPHOS is unchanged between 1-6 months, this 
observation would suggest that similar amount of myocardial thickening 
contraction requires less supporting  ATP in Month 6 as compared to Month 1.  
The mechanism for this observation warrants future studies such as using tagged 
MRI to track 3D regional myocardial motion vectors in modeling the efficiency of 
LV ejection [136-137] 
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Preserved Baseline Myocardial Energetics in chronic hibernating 
myocardium 
 
In short term hibernation myocardium, sequential biopsy-based measurements of 
ATP, creatine phosphate, creatine, and inorganic phosphate revealed a decrease 
in the free energy change of ATP hydrolysis during early ischemia with a 
subsequent recovery during continued 90 min ischemia [127]. A key feature of 
this study is that the myocardial energetic state as measured by in vivo NMR 
spectroscopy is stable in chronic hibernating myocardium. Energetic state refers 
to delta G which is the free energy of ATP hydrolysis [125].  ∆GATP 
(kJ/mol) = ∆G° − RT ln ([ATP]/[ADP][Pi]), where ∆Go (− 30.5 kJ/mol) is the value 
of ∆GATP under standard conditions of molarity, temperature, pH, and [Mg2+], R is 
the gas constant (8.3 J/mol K), and T is temperature (Kelvin). Delta G  is linearly 
related to the myocardial PCr/ATP [125]. The set point of the driving force and 
the efficiency of mitochondria ATP production (mtOXPHOS) are reflected by the 
myocardial PCr/ATP (delta G).  In chronic heart failure or acute myocardial 
ischemia, the myocardial energetic state is decreased as reflected by a decrease 
in PCr/ATP [90, 126]. Baseline high energy phosphate levels have been 
previously studied in animal models of hibernating myocardium and human 
hibernating myocardium with differing results [75, 122-124]. Elsasser et al 
studied 16 patients with coronary artery disease and left ventricular dysfunction 
who had documented hibernating myocardium detected by thallium-201 
scintigraphy, radionuclide ventriculography and low-dose dobutamine 
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echocardiography [122]. All these patients had improvement of LV function with 
revascularization [122]. Myocardial biopsy specimens from the hibernating 
myocardium regions revealed significant depression of creatine phosphate, 
adenosine triphosphate and creatine, a significant increase in lactate levels and 
acidosis [122]. They concluded that hibernating myocardium demonstrated a 
decrease in free energy of ATP hydrolysis and thus is energy depleted [122]. 
Wiggers at al studied the myocardial energetics in 25 patients with CAD and LV 
dysfunction but these authors further categorized the dysfunctional myocardium 
into reversible (hibernating) and irreversible based on improvement after 
revascularization [124]. Biopsy specimens revealed similar ATP/ADP ratio, 
lactate levels and glucose uptake in hibernating and remote myocardium; 
however, the irreversible myocardium had significantly decreased ATP/ADP ratio 
and glucose uptake and significantly increased lactate levels [124]. In contrast to 
Elsasser’s paper, these authors concluded that the energy stores in hibernating 
myocardium are well preserved [122, 124]. One of the reasons for this 
discrepancy could be the increased fibrosis (30%) in the hibernating myocardial 
specimens in the Elsasser study [122]. In a porcine model of chronic hibernating 
myocardium, Hu et al report normal baseline total creatine, creatine phosphate 
and ATP/ADP in biopsy specimens from hibernating myocardium 3 months after 
placement of an ameroid occluder [123]. These authors did observe a global 
reduction of absolute ATP, ADP and Total adenine nucleotide (TAN) levels in the 
hibernating myocardium but despite these reductions the overall energetic state 
as determined by the ATP/ADP and CP levels was preserved [123]. Our group 
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has the unique opportunity to study the myocardial energetics in vivo with NMR 
spectroscopy as opposed to measuring the levels of HEP in vitro in biopsy 
specimens. We previously have shown that the myocardial energetic state as 
determined by PCr/ATP ratio is maintained at 10 weeks in a porcine model of 
chronic hibernating myocardium [75].  We unfortunately were not able to perform 
a longer follow-up on these animals because of their large size. In the current 
study, a mini-pig model of chronic hibernating myocardium allowed us to study 
the myocardial energetics up to 6 months follow-up. We demonstrate that the 
transmural PCr/ATP ratio is normal in hibernating myocardium at 6 months 
reflecting a stable energetic state despite a reduction in regional blood flow and 
function. Furthermore, H1 NMR spectroscopy did not reveal any deoxymyoglobin 
showing that these tissues are not ischemic despite a reduction in blood flow. 
The preservation of a stable energetic state reflects the ability of hibernating 
myocardium to balance the supply and demand and this may be achieved by 
intrinsic downregulation of its metabolic needs. Using a proteomic approach, 
Page et al have shown that hibernating myocardium developed a significant 
downregulation of many mitochondrial proteins such as proteins involved in the 
major entry points to oxidative metabolism (eg, pyruvate dehydrogenase complex 
and Acyl-CoA dehydrogenase) and enzymes involved in electron transport (eg, 
complexes I, III, and V) [138].  
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Response to increased work load in hibernating myocardium 
 
The animals with hibernating myocardium demonstrated an appropriate 
hemodynamic response to inotropic stimulation with a subnormal increase in 
blood flow and regional function. It has been shown previously in a short term 
hibernation model that inotropic stimulation with dobutamine for 5 minutes 
increases contractile function without increasing blood flow and disrupts the 
recovery of creatine phosphate and lactate consumption. If inotropic stimulation 
is maintained for 90 minutes, the metabolic deterioration is followed by 
myocardial infarction [139]. In our present study, the increased work load was 
associated with a decrease in the PCr/ATP ratio which is similar to the decrease 
seen in normal myocardium previously at a similar workload (RPP approximately 
23000). Thus, the hibernating myocardium has a “stable” energetic state, that is 
similar to normal myocardium. The decreased PCr/ATP ratios during dobutamine 
infusion probably reflect a change in the kinetics of oxidative phosphorylation or 
intermediary metabolic steps rather than a myocyte oxygenation–related 
limitation of ATP synthetic capacity. In contrast to this response in chronic 
hibernating myocardium, we have previously demonstrated a dramatic decrease 
in PCr/ATP ratio after dobutamine stimulation in animals with moderate acute 
coronary artery stenosis. At this level of acute coronary artery stenosis with a 
state of abolished coronary flow reserve and a minor decrease of myocardial 
blood flow, there is mild reduction of PCr/ATP at basal cardiac workstate 
(PCr/ATP~ 1.99), but a marked further reduction of PCr/ATP ( to ~1.40 ) during 
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higher cardiac workstate [140]. It is possible that intrinsic changes in the 
mitochondria that reduce oxidant damage within hibernating myocardium 
preserve energy at high work states. Hu et al have shown that hibernating 
myocardium has a significant reduction in mitochondrial function in vitro as 
reflected by a significant reduction in the respiratory control ratio mainly due to a 
decrease in state 3 respiration [123]. This was also shown by McFalls et al who 
studied isolated mitochondria from hibernating myocardium and demonstrated a 
decreased respiratory control ratio [76]. They further demonstrated that the 
reduction in oxidant damage may also be related to an increase in uncoupling 
protein 2 in hibernating myocardium [76]. 
 
Conclusion 
 
Thus, long term chronic hibernating myocardium has a relatively well preserved 
stable energetic state despite a reduction in regional blood flow and function. 
This is probably related to an intrinsic down-regulation in the mitochondrial 
function which minimizes oxidative stress and leads to a balanced supply and 
demand at baseline and increased work load.  
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Figure Legends 
 
Fig 1. Temporal changes in Myocardial blood flow in chronic hibernating 
myocardium as measured by First Pass Perfusion MRI.  *, p < 0.05. 
 
Fig 2. Myocardial Perfusion Reserve is diminished in chronic hibernating 
myocardium. A. Transmural MBF data at 6 months using microsphere method. 
Values are Mean±SD, *, p<0.05 as compared to Remote; †, p<0.05 as compared 
to Baseline. B. Graphical display of the full thickness MBF changes with 
adenosine in remote and hibernating myocardium. 
 
 
Fig 3. Temporal changes in regional ventricular function in chronic hibernating 
myocardium.. A. Tabular summary of wall thickness and systolic thickening 
fraction. Values are Mean±SD. ESWT, end-systolic wall thickness; EDWT, end-
diastolic wall thickness; *, p<0.05 as compared to remote. B. Graphical display of 
systolic thickening fraction over time. *, p<0.05. 
 
Fig 4. Response to increased cardiac work load in chronic hibernating 
myocardium. 
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Table 1: Ventricular volumes, mass and ejection fraction 
 
Time 
Period 
EDV (ml) ESV (ml) SV (ml) EF (%) LVED Mass (g) 
Baseline 16.9±2.6 
 
7.6±1.8 
 
9.3±0.8 
 
55.1±2.2 35.20±2.2 
2 week 19.6±1.3 
 
8.9±1.0 
 
10.7±0.5 
 
55.5±2.5 
 
36.10±2.4 
1 month 16.7±2.6 
 
7.7±1.9 
 
9.0±1.1 
 
55.2±4.5 
 
36.42±2.8 
4 month 26.9±3.1* 
 
11.3±0.1*
 
15.5±3.2*
 
57.2±2.6 40.63±3.8* 
6 month 26.9±4.3* 
 
11.9±2.2*
 
15.1±2.5*
 
56.2±3.6 
 
44.12±3.6* 
 
Values are Mean±SD. *, p<0.05 as compared to Baseline. 
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Table. 2: Hemodynamic Data 
 
 Baseline Increased 
Workload 
p-value 
Heart Rate (bpm) 101.6±14.9 153±32.7 0.019 
LVSP (mmHg) 103.8±16.5 160±40.5 0.04 
RPP ( x 103) 10.6±2.3 25.0±10.8 0.04 
 
Values are Mean±SD; RPP, Rate Pressure Product. 
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Table 3: Transmural High Energy endocardial/epicardial PCr/ATP ratios 
 
 Epi Endo FT 
Hibernating 
Myocardium 
   
Baseline 2.33±0.09 1.88±0.06 2.25±0.21 
Increased Work Load 1.94±0.10* 1.65±0.14* 1.84±0.23* 
Control  
(Minipigs)  
   
Baseline 2.13±0.08 1.97±0.06 2.06±0.06 
Historical Control 
(Normal Pigs) 
   
Baseline 2.23±0.08 1.92±0.08 2.18±0.06 
Increased Work Load 1.73±0.09* 1.64±0.09* 1.70±0.08* 
 
Values are Mean±SD; *, p < 0.05 as compared to baseline within group. 
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CHAPTER 6: ATP SENSITIVE K+ CHANNELS ARE CRITICAL FOR 
MAINTAINING MYOCARDIAL PERFUSION AND HIGH ENERGY 
PHOSPHATES IN THE FAILING HEART 
 
Mohammad N Jameel, MD, Qinglu Li, BS, Abdul Mansoor, MD, PhD, Xiong 
Qiang, MS, Robert Bache, MD, Jianyi Zhang, MD, PhD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 132 
Congestive heart failure (CHF) is associated with intrinsic alterations in 
mitochondrial oxidative phosphorylation which are independent of ischemia and 
manifest as an increase in myocardial cytosolic free ADP. ATP sensitive K+ 
channels (KATP) act as metabolic sensors that are important for maintaining 
coronary blood flow (CBF) and in mediating the response of the myocardium to 
stress. Coronary adenosine receptors (AdR) are not normally active but cause 
vasodilation during myocardial ischemia. This study examined the myocardial 
energetic response to inhibition of KATP and AdR in CHF. CHF (as evidenced by 
LVEDP > 25 mmHg) was produced in adult mongrel dogs (n=12) by rapid 
ventricular pacing (220-250) for 4 weeks. CBF was measured with radiolabeled 
microspheres in open chest dogs during baseline (BL), AdR blockade with 8-
Phenyltheophylline (8-PT; 5mg/kg iv) and KATP blockade with Glibenclamide 
(GLB; 20 µg/kg/min ic), while high energy phosphates were examined with 31P 
magnetic resonance spectroscopy (MRS).  Myocardial oxygenation was 
examined from the deoxymyoglobin signal using 1H MRS (Mb-δ). During basal 
conditions Mb-δ was undetectable while phosphocreatine (PCr)/ATP (1.78±0.15) 
was significantly lower than in previously studied normal dogs (2.42±0.11). 8-PT 
caused a ≈ 21% increase in CBF (0.71±0.07 at BL vs 0.90±0.15 ml/min-g with 8-
PT) with no change in PCr/ATP (1.65±0.17 with 8-PT vs 1.78±0.15 at BL, p=NS). 
GLB resulted in a 32.7±0.1% decrease in CBF (to 0.58±0.07 ml/min-g, p=0.02) 
that was associated with a decrease in PCr/ATP (1.11±0.11 with GLB vs 
1.65±0.17 with 8-PT, p<0.0001). The pseudo-first-order rate constant of ATP 
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production via CK (kf) did not change during GLB.  However, the ATP production 
rate via CK was reduced by 35±0.08% during GLB, and this was accompanied 
by a significant increase in Pi/PCr and a Mb-δ signal indicating tissue hypoxia. 
Thus, in the failing heart without coronary artery disease, the balance between 
myocardial ATP demands (or oxygen demands) and delivery are critically 
dependent on functioning KATP channels but not AdR.  
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Introduction 
 
ATP sensitive potassium (KATP) channels are present on the sarcolemma of 
coronary vascular smooth muscle cells and cardiac myocytes and on the 
mitochondrial inner membrane and play an important role in the cardiovascular 
system [141-144]. The opening of the KATP channels on vascular smooth muscle 
cells results in an outward flux of potassium causing hyperpolarization of the 
sarcolemma that subsequently closes voltage-dependent calcium channels, 
leading to a decreased influx of calcium, thereby causing vasodilation [145]. KATP 
channel activity is modulated by metabolic signals, with an increase in ADP/ATP 
ratio near the sarcolemma, acidosis, and hypoxia all directly activating KATP 
channels [146]. Intracoronary glibenclamide (inhibitor of KATP channels) in doses 
of 10–50 µg·kg–1·min–1 causes coronary vasoconstriction with a 20–55% 
decrease in basal coronary blood flow (CBF) in open-chest dogs or awake resting 
dogs, resulting in reduced coronary venous oxygen tension at a given level of 
myocardial oxygen consumption (MVO2)  [147-150]. The decrease in CBF 
produced by KATP channel blockade is associated with a decrease in regional 
systolic wall thickening [147-149]. We have previously shown that the decrease 
in CBF produced by glibenclamide causes a decrease in PCr/ATP and an 
increase in inorganic phosphate that is associated with a prominent 
deoxymyoglobin resonance which is substantially greater than when a similar 
decrease of coronary flow was produced by a stenosis [61]. These findings 
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suggested that reduction of CBF with an arterial stenosis was associated with a 
decrease of myocardial energy demands and that this response to hypoperfusion 
was inhibited by KATP channel blockade [61]. Mitochondrial KATP channels 
mediate cardioprotection presumably by mediating K+ influx along mitochondrial 
inner membrane potential (∆Ψm) and causing a decrease in ∆Ψm, matrix 
swelling and regulation of reactive oxygen species (ROS) generation [151]. We 
have previously shown that glibenclamide decreases MVO2 by a decrease in 
CBF and oxygen availability rather than due to a primary reduction of 
mitochondrial respiration [61, 152].  
 
Adenosine is a potent vasodilator, but it does not participate in regulation of 
coronary flow under physiological conditions [153]. However, adenosine does 
contribute to coronary vasodilation when there is an insufficient supply of oxygen 
[154]. Thus, adenosine receptor blockade with intravenous 8-phenyltheophylline  
caused a decrease in the total volume of excess flow during reactive hyperemia 
following a brief total coronary artery occlusion in dogs [153]. 
 
Congestive Heart Failure (CHF) is associated with a decrease in CBF that is 
matched to a decrease in MVO2 suggesting a down-regulation of energy 
utilization [60]. KATP channel blockade with intracoronary glibenclamide resulted 
in a decrease in CBF and MVO2 without a change in the relationship between 
CBF and MVO2 in CHF animals [62]. On the other hand, adenosine receptor 
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blockade in CHF caused a significant increase in CBF that occurred secondary to 
an increase in MVO2 [62]. 
  
Our group has studied high energy phosphate metabolism in animals with 
congestive heart failure using in vivo NMR spectroscopy [51, 131, 155]. This has 
revealed significant bioenergetic abnormalities in animals with CHF which are 
characterized by a lower ATP, CP, creatine and PCr/ATP ratio [51, 131, 155]. 
The myocardial calculated free ADP levels were also significantly increased in 
CHF hearts [51, 131, 155]. The increase in myocardial free ADP is associated 
with reductions in mitochondrial F0F1-ATPase protein expression[51]. CK-M and 
CK-mito protein levels were decreased along with significant decreases in CK 
flux rate [51, 131, 155]. Furthermore, in CHF hearts, the low basal PCr/ATP 
occurred in the absence of myocardial hypoxia, indicating that the HEP 
abnormalities were not the result of insufficient oxygen availability [51, 131, 155]. 
 
The aim of the present study was to investigate the bioenergetic response to 
KATP channel blockade and adenosine receptor blockade in animals with pacing 
induced heart failure using in vivo NMR spectroscopy.  
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Methods 
 
All experiments were performed in accordance with the animal use guidelines of 
the University of Minnesota, and the experimental protocol was approved by the 
University of Minnesota Research Animal Resources Committee. The 
investigation conformed to the “Guide for the care and use of laboratory animals” 
published by the National Institutes of Health (NIH publication No 85-23, revised 
1985). 
  
Surgical Instrumentation and Production of CHF 
 
Studies were performed in 12 adult mongrel dogs of either sex weighing 20-27 
kg.  CHF was produced by rapid ventricular pacing in 6 adult mongrel dogs as 
previously described [60, 62]. Briefly, animals were premedicated with 
acepromazine (10 mg IM), anesthetized with sodium pentobarbital (30 to 35 
mg/kg IV), intubated, and ventilated with room air supplemented with oxygen to 
maintain arterial blood gasses in the physiological range. A left thoracotomy was 
performed in the fifth intercostal space. A heparin-filled polyvinyl chloride catheter 
(3.0 mm OD) was introduced into the internal thoracic artery and advanced until 
the tip was positioned in the ascending aorta. The pericardium was opened, and 
the heart was suspended in a pericardial cradle. A second catheter was placed 
into the left atrium through the atrial appendage and secured with a purse-string 
 138 
suture. A similar catheter was introduced into the right atrium, manipulated into 
the coronary sinus ostium, and advanced until the catheter tip could be palpated 
in the great cardiac vein at the origin of the anterior interventricular vein to permit 
venous blood sampling from the myocardial region perfused by the left anterior 
descending coronary artery (LAD). A fluid-filled catheter and a high-fidelity 
Konigsberg micromanometer were placed in the left ventricle at the apex and 
secured in place. The proximal LAD was dissected free, and a Doppler velocity 
probe (Craig Hartley) was placed around the vessel. A heparin-filled silicone 
rubber catheter (0.75 mm ID) was introduced into the artery distal to the occluder 
[156]. Finally, a unipolar epicardial pacing lead (Medtronic Inc) was screwed into 
the right ventricle, and the pericardium was then loosely closed. All catheters and 
electrical leads were tunneled subcutaneously to exit at the base of the neck. The 
thoracotomy was closed in layers and evacuated of air. A programmable pacing 
generator modified to allow rapid pacing (Medtronic 5385) was placed in a 
subcutaneous pocket in the lateral chest wall and connected to the pacing lead. 
Catheters were flushed daily with heparin to maintain patency and were protected 
with a nylon vest. One week after surgery the pacemaker was activated at 220 
bpm. This rate was continued or increased to 250 bpm if evidence of CHF was 
not present within 3 weeks. Resting hemodynamics and CBF were assessed 
weekly in normal sinus rhythm 1 hour after the pacemaker was deactivated. CHF 
was deemed to have developed when LV end-diastolic pressure was > 
25mmHG.  
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Experimental preparation for MRS study.   
 
Detailed surgical preparations for MRS study are published previously [56, 77, 
91]. Briefly, the dogs were anesthetized with sodium pentobarbital (30-35 mg/kg 
bolus followed by 4 mg/kg/hr, i.v.), intubated and ventilated with a respirator with 
supplemental oxygen to maintain arterial blood gases within the physiologic 
range.  A heparin-filled polyvinyl chloride catheter, 3.0 mm o.d., was introduced 
into the right femoral artery and advanced into the ascending aorta.  A left 
thoracotomy was performed through the fourth intercostal space and the heart 
suspended in a pericardial cradle.  A heparin-filled catheter (3.0 mm o.d.) was 
introduced into the left ventricle through the apical dimple and secured with a 
purse string suture.  A similar catheter was inserted into the left atrium through 
the atrial appendage.  A home made intra-cardiac vein catheter (0.3 mm o.d) was 
inserted directly into the great cardiac vein for coronary vein blood sampling.  
The region of the left ventricle that became cyanotic upon inflation of the LAD 
occluder was determined by visual inspection and a 28 mm diameter MRS 
surface coil was sutured onto the pericardium overlying the ischemic area.  The 
pericardial cradle was then released and the heart allowed to assume its normal 
position.  The surface coil leads were connected to a balanced tuned circuit and 
the animals were placed in the magnet. 
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MRS spectroscopy-general methods 
 
Measurements were performed in a 40 cm bore 4.7 Tesla magnet interfaced with 
a SISCO (Spectroscopy Imaging Systems Corporation, Fremont, CA) console.  
The left ventricular pressure signal was used to gate MRS data acquisition to the 
cardiac cycle, while respiratory gating was achieved by triggering the ventilator to 
the cardiac cycle between data acquisitions [157-158].  
31
P and 
1
H-MRS 
frequencies were 81 MHz and 200.1 MHz, respectively. 
 
MRS deoxy-myoglobin methods.  
 
1H NMR methods have been previously reported in detail [54, 92]. The method 
for 
1
H-MRS detection of the proximal histidyl N-δ proton resonance of Mb-δ has 
also been described [159].  Briefly, a single-pulse collection sequence with a 
Gaussian pulse (1 ms) was used to selectively excite the N-δ proton signal of the 
proximal histidyl of Mb-δ.  This frequency selective pulse provided sufficient 
water suppression due to the large chemical shift difference between the water 
resonance and Mb-δ (>14 kHz).  A short repetition time (TR=35 ms) was used 
due to the short T1  value of Mb-δ.  Each spectrum is acquired within 6 min 
(10,000 FID).  Although the short T1 of Mb-δ and the fast acquisition prevent 
gating of data acquisition to the cardiac cycle, signal loss as a result of heart 
motion was negligible because of the inherently broad line width of the Mb-δ 
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peak.  Although the Mb-δ resonance is temperature sensitive, the chemical shift 
of this resonance which appeared at 71-72 ppm (relative to H2O), remained 
virtually constant during the study protocol.  No other resonances were detected 
within a 10 ppm region.  In phantom studies we have established that the 
detection sensitivity for Mb-δ is essentially flat across the wall of the left ventricle.  
Therefore, the Mb-δ resonance reflects average whole wall Mb-δ without the 
need for correction for differences in sensitivity in the deeper myocardial layers 
as is the case for HEP measurements (see below).    
 
Spatially localized 31P MRS technique.   
 
31P MR spectra were acquired in late diastole with a pulse repetition time of 6-7 
seconds.  This repetition time allowed full relaxation for ATP and Pi resonances, 
and approximately 90% relaxation for the PCr resonance.  PCr resonance 
intensities were corrected for this minor saturation.  RF transmission and signal 
detection were performed with a 28 mm diameter surface coil.  A capillary 
containing 15 µl of 3M phosphonoacetic acid was placed at the coil center to 
serve as a reference.  The proton signal of the water resonance was used to 
homogenize the magnetic field and to adjust the position of the animal in the 
magnet so that the coil was at or near the magnet and gradient isocenter.  This 
was accomplished using a spin-echo experiment with a readout profile.  The 
information gathered in this step was also utilized to determine the spatial 
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coordinates for spectroscopic localization.  Chemical shifts were measured 
relative to PCr which was assigned a chemical shift of -2.55 ppm relative to 85% 
phosphoric acid at 0 ppm.  Spatial localization across the left ventricular wall was 
performed with the RAPP-ISIS/FSW method.  The technical details of this 
method including voxel profiles, voxel volume, and the accuracy of spatial 
localization obtained in phantom studies and in vivo have been published 
elsewhere [158, 160-161].  Briefly, signal origin was restricted using B0 gradients 
and adiabatic inversion pulses to an 18 mm x 18 mm column coaxial with the 
surface coil and perpendicular to the left ventricular wall.  Within this volume, the 
signal was further localized using the B1 gradient to 5 voxels spanning the left 
ventricular wall from epicardium to endocardium.  Each set of spatially localized 
transmural spectra consisted of a total of 96 scans accumulated in a 10 minute 
block.  Resonance intensities were quantified using integration routines provided 
by SISCO software.  The values for PCr and ATP in each voxel were normalized 
to those present in the basal state and the PCr /ATP ratio was determined for 
each voxel.  Pi resonances were also measured and ratio of Pi/ PCr was 
calculated. 
 
The Mb-δ resonance detected using the present methodology represents an 
unweighted average of the Mb- δ content across the entire LV wall.  A 
comparable whole wall measurement of HEP levels does not exist, because the 
sensitivity for detection of the phosphorus resonance decreases as a function of 
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distance from the surface coil.  Therefore, average whole wall values of HEP 
were obtained by averaging the HEP contents in the subepicardial, midwall and 
subendocardial voxels that were acquired with our spatially localized 
spectroscopy technique [161].  This technique corrects voxel HEP content 
measurements for the decrease sensitivity which occurs with increasing distance 
from the surface coil, thereby yielding true average whole wall PCr and ATP 
contents.  
 
Myocardial blood flow measurements  
 
Myocardial blood flow was measured using radionuclide labeled microspheres, 
15 µm in diameter labeled with 4 different radioisotopes (51Cr, 85Sr, 95Nb and 
46Sc).  Microsphere suspension containing 2x106
 
microspheres was injected 
through the left atrial catheter while a reference sample of arterial blood was 
withdrawn from the aortic catheter at a rate 15 ml/min beginning 5 seconds 
before the microsphere injection and continuing for 120 seconds.  Radioactivity in 
the myocardial and blood reference specimens was determined using a gamma 
spectrometer (Packard Instrument Company, Downers Grove, IL) at window 
settings chosen for the combination of radioisotopes used during the study.  
Activity corrected for overlap between isotopes and for background was used to 
compute blood flow as ml/g of myocardium/minute. 
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Study protocol.  
 
Aortic and left ventricular pressures were measured with fluid filled pressure 
transducers positioned at mid-chest level and recorded on an 8-channel direct 
writing recorder (Coulbourne Instrument Company, Lehigh Valley, PA).  Left 
ventricular pressure was recorded at normal and high gain for measurement of 
end-diastolic pressure.  Hemodynamic measurements and 31P and 1H MRS 
spectra were first obtained under basal conditions.  Midway through the 20 min 
data acquisition period, a microsphere injection was performed for determination 
of myocardial blood flow. After completion of baseline measurements, adenosine 
receptor blockade was produced by administration of 8-Phenyltheophylline (8-
PT; 5mg/kg iv). This dose has been previously shown to produce >90% inhibition 
of the coronary vasodilator response to adenosine while causing minimal 
phosphodiesterase inhibition. Hemodynamic measurements and 31P and 1H MRS 
spectra were acquired under 8-PT infusion along with another microsphere 
injection. This was followed by intracoronary infusion glibenclamide at 20 
µg/kg/min. After 10 minute was allowed to achieve steady state conditions, 31P 
and 1H MRS spectra. 
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Data analysis.   
 
Hemodynamic data were measured from the chart recordings. 31P spectra were 
analyzed as described above.  Transmural blood flow distribution was 
determined from the microsphere measurements.  Data were analyzed with one-
way analysis of variance for repeated measures.  A value of p<0.05 was 
considered significant.  When a significant result was found, individual 
comparisons were made using the method of Sheffé. 
 
Results 
 
Hemodynamic Data  
 
Rapid ventricular pacing resulted in heart failure in all the dogs with a 
documented LV end-diastolic pressure of greater than 25 mmHg. Hemodynamic 
measurements during each experimental condition in anaesthetized dogs are 
shown in Table 1. At baseline, these heart failure dogs had a lower mean aortic 
pressure, lower LV systolic pressure and higher LV end-diastolic pressure as 
compared with normal dogs previously studied in our laboratory [61]. Infusion of 
8-PT resulted in a significant increase in heart rate and consequently higher rate 
pressure product. Infusion of glibenclamide caused no further change in heart 
rate, mean aortic pressure or LV systolic pressure but increased LV end-diastolic 
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pressure from 19±2 to 29±2 mmHg (p<0.05), suggesting a deterioration in LV 
function as previously demonstrated in normal dogs after K+ATP channel 
blockade [61]. 
 
Myocardial Blood Flow  
 
Table 2 summarizes the myocardial blood flow (MBF) data under different 
experimental conditions. Resting mean MBF was 0.71±0.07 ml/min-g with a 
subendocardial-to-subepicardial ratio of 1.17±0.08. Adenosine receptor blockade 
caused an approximately 21% increase in mean MBF (0.71±0.07 at BL vs 
0.90±0.15 ml/min-g with 8-PT, p<0.05) with no change in the transmural gradient. 
On the other hand, subsequent K+ATP channel blockade resulted in a 
32.7±0.1% decrease in MBF (0.90±0.15 ml/min-g with 8-PT vs 0.58±0.07 ml/min-
g with 8-PT+GLIB, p<0.05). The reduction of blood flow produced by 
glibenclamide was more pronounced in the subepicardium than in the 
subendocardium resulting in a significant increase in the subendocardial-to-
subepicardial ratio from 1.13±0.14 to 1.42±0.15 (p<0.05). This is in contrast to 
previously studied dogs with coronary occlusion in which the decrease in MBF is 
most marked in the subendocardium with a decrease in the subendocardial-to-
subepicardial flow ratio [61]. 
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Transmural Myocardial High Energy Phosphates and Oxygenation  
 
Spectra obtained during baseline conditions demonstrated prominent resonances 
corresponding to PCr and the three phosphates of ATP, whereas Pi was below 
the limit of detectability. Transmural high energy phosphate levels during different 
experimental conditions are depicted in Table 3. The PCr/ATP ratio during 
baseline conditions was 1.78±0.15 with the subendocardial layer showing the 
lowest ratio. This was significantly lower than previously studied normal dogs 
(2.42±0.11) and was not the result of ischemia as no deoxymyoglobin (Mb-δ) 
was detected. Adenosine receptor blockade caused no significant change in the 
PCr/ATP ratio despite an increase in myocardial blood flow. However, 
glibenclamide resulted in a significant decrease of PCr but no change of ATP, 
resulting in a significant decrease in the PCr/ATP ratio (1.11±0.11 with 8-
PT+GLIB vs 1.65±0.17 with 8-PT, p<0.05). The transmural gradient was 
maintained with the subendocardium showing the worst energetic state despite a 
more prominent decrease in blood flow in the subepicardium. This was 
accompanied by a significant increase in ∆Pi/PCr and appearance of Mb-δ signal 
indicating tissue hypoxia.  
 
 
 
 
 148 
Creatine Kinase Flux  
 
The Creatine Kinase kinetics data is depicted in Table 4. The pseudo-first-order 
rate constant of ATP production via CK (kf) did not change during either 
adenosine receptor or K+ATP channel blockade.  However, the ATP production 
rate via CK was reduced by 35±0.08% during K+ATP channel blockade 
(Normalized CK flux rate with 8-PT was 1.13±0.26 vs 0.73±0.08 with 8-PT+GLIB, 
p<0.05). 
 
Discussion 
 
This is the first report examining the effect of adenosine and K+ATP channel 
blockade on myocardial energetics in the failing heart. We demonstrate that 
adenosine receptor blockade did not improve myocardial energetics in the failing 
heart despite an increase in myocardial blood flow. On the other hand, K+ATP 
channel blockade in the failing heart is associated with a significant decreases in 
the PCr/ATP ratio and the ATP production rate via CK which is associated with a 
decrease in myocardial blood flow and tissue hypoxia. Thus, in failing hearts 
without coronary artery disease, the balance between myocardial ATP demands 
(or oxygen demands) and delivery are critically dependent on functioning KATP 
channels but not on adenosine receptors.   
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Myocardial Energetics in Heart Failure  
 
Our results confirm our previous findings that heart failure is associated with a 
decrease in PCr/ATP ratio that is not the result of ischemia [51, 131, 155]. It has 
been shown that this decrease in PCr/ATP ratio is associated with a decrease in 
CK flux [51, 131, 155] and change in substrate utilization with decreased fatty 
acid oxidation [162].  
 
Adenosine Receptor Blockade in Heart Failure  
 
We have previously shown that in the failing heart adenosine receptor blockade 
causes an increase in myocardial blood flow that appears to be secondary to an 
increase in myocardial oxygen consumption [62]. However, 8-PT did not alter the 
relationship between myocardial oxygen consumption and coronary venous pO2, 
implying that it did not alter metabolic signaling between myocardial myocytes 
and the coronary resistance vessels [62]. The present study confirms our 
previous report of an increase in MBF with adenosine receptor blockade. More 
importantly, it shows that 8-PT did not have any impact on myocardial energetics, 
supporting the notion that adenosine receptors do not play a role in maintaining 
the metabolic balance between myocardial ATP demands (or oxygen demands) 
and delivery in the failing heart. 
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K+ATP channel blockade in Heart failure  
 
We have previously shown that in normal animals KATP channel blockade inhibits 
the decrease in myocardial energy demands in response to hypoperfusion [61]. 
Our present study demonstrates that glibenclamide results in a significant 
reduction in PCr/ATP ratio and ATP production rate in failing hearts that is 
associated with tissue hypoxia. This is probably related to an inability to decrease 
myocardial oxygen consumption in response to a decrease in blood flow. This 
implies that KATP channels play a pivotal role in maintaining the balance between 
ATP demand and delivery in the failing hearts. 
 
Conclusion 
 
KATP channels but not adenosine receptors are important in maintaining the 
balance between oxygen delivery and demand in the failing heart. 
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Table 1. Hemodynamic Data  
 
 
 HR 
(Beats/min) 
MAP 
(mmHg)
LVSP 
(mmHg)
LVEDP 
(mmHg)
RPP 
(Beats.mmHg.
min-1 x10-3) 
Baseline 102±8 82±4 102±5 19±2 10.4±0.8 
8-PT 120±10* 88±7 104±6 20±2 12.6±1.3* 
8-PT + 
GLIB 
121±11* 86±8 100±7 29±2*† 12.2±1.1* 
 
Values are means ± SE. 8-PT, 8-Phenyltheophylline at 5mg/kg intravenous; 
GLIB, Glibenclamide at 20 µg/kg/min intracoronary; HR, Heart rate; MAP, Mean 
Aortic Pressure; LVSP, Left ventricular systolic pressure; LVEDP, Left ventricular 
end-diastolic pressure; RPP, rate pressure product; *, p<0.05 vs. baseline; †, 
p<0.05 vs. 8-PT. 
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Table 2. Myocardial Blood Flow 
 
 EPI MID ENDO Mean Endo/Epi 
Baseline 0.64±0.07 0.75±0.08 0.74±0.08 0.71±0.07 1.17±0.08 
8-PT 0.83±0.12* 0.92±0.17* 0.94±0.18* 0.90±0.15* 1.13±0.14 
8-
PT+GLIB 
0.47±0.05*† 0.63±0.11† 0.65±0.08† 0.58±0.07*† 1.42±0.15†
 
Values are means ± SE. 8-PT, 8-Phenyltheophylline at 5mg/kg intravenous; 
GLIB, Glibenclamide at 20 µg/kg/min intracoronary; EPI, subepicardium; MID, 
midmyocardium; ENDO, subendocardium; *, p<0.05 vs. baseline; †, p<0.05 vs. 
8-PT. 
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Table 3: Myocardial high-energy phosphate levels 
 
 PCr/ATP ∆Pi/PCr Normalized 
PCr 
Normalized 
ATP 
 EPI ENDO Mean Mean Mean Mean 
Baseline 1.90±0.14 1.62±0.15 1.78±0.15 0 1 1 
8-PT 1.68±0.12 1.36±0.11 1.65±0.17 0 0.92±0.06 0.99±0.08 
8-PT 
+GLIB 
1.34±0.06*† 0.81±0.23*† 1.11±0.15*† 0.63±0.26*† 0.65±0.09*† 1.02±0.09 
 
Values are means ± SE. 8-PT, 8-Phenyltheophylline at 5mg/kg intravenous; GLIB, Glibenclamide at 20 µg/kg/min 
intracoronary; Pi, Inorganic phosphate; PCr, Phosphocreatine; ATP, Adenosine Triphosphate; EPI, subepicardium; 
ENDO, subendocardium; *, p<0.05 vs. baseline; †, p<0.05 vs. 8-PT. 
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Table 4. Creatine Kinase Kinetics 
 
 ∆M/M Tau 
(sec) 
T1 
(sec) 
kf 
(sec-1) 
Normalized  
CK flux rate
Baseline 0.64±0.07 1.37±0.12 4.33±0.84 0.47±0.06 1 
8-PT 0.62±0.07 1.17±0.14 3.28±0.37 0.58±0.14 1.13±0.26 
8-
PT+GLIB 
0.66±0.06 1.47±0.07 4.55±0.82 0.48±0.04 0.73±0.08* 
 
Values are means ± SE. 8-PT, 8-Phenyltheophylline at 5mg/kg intravenous; 
GLIB, Glibenclamide at 20 µg/kg/min intracoronary; ∆M/M, relative change of 
PCr resonance intensity; Tau, time constant that fits the integral of PCr 
magnetization decay as the time of saturation of ATPγ increased from 0 to 
infinite; T1, longitudinal relaxation time;  kf, forward rate constant of creatine 
kinase; *, p<0.05 vs. baseline. 
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CHAPTER 7: CONCLUSIONS 
 
In the current thesis, we demonstrated that trans-coronary artery injection of 
bone marrow derived multiprogenitor cells in a clinically relevant porcine model of 
ischemia/reperfusion is safe, feasible and effective. Stem cell transplantation 
resulted in improvement of ventricular function at 4 weeks after myocardial 
infarction. Cell transplantation was associated with an increase in vascular 
density, inhibition of apoptosis and reduction of infarct size, which was 
accompanied by improvement in border zone and infarct zone contractile 
function, with consequent improvement in myocardial bioenergetics and global 
LV function.  These functional beneficial effects were observed despite a low 
engraftment of stem cells at 4 weeks.  In vitro, the stem cells significantly 
inhibited TNFα induced mitochondrial membrane potential change and 
cytochrome C release from myocytes. Additionally, coculture of stem cells with 
HL-1 cells inhibited TNFα induced apoptosis. Thus, the beneficial effects of stem 
cell transplantation are most likely related to the “trophic effects” of cells on the 
host myocardium, which include promotion of angiogenesis, maintenance of 
mitochondrial integrity, and inhibition of apoptosis of ischemia threatened and 
overstretched myocytes in the border zone myocardium.  
 
In subsequent experiments, we demonstrated that stem cell transplantation leads 
to long term functional and bioenergetic improvement in a clinically relevant 
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porcine model of postinfarction LV remodeling despite no significant engraftment 
of cells at 4 months in the heart. Stem cell transplantation resulted in a decrease 
in LV hypertrophy and amelioration of LV dilatation. This was associated with a 
reduction in scar size at 4 months. Cell transplantation also resulted in long term 
differential expression of genes which included a downregulation of mitochondrial 
oxidative enzymes and upregulation of MEF2a and ZFP91. Thus, stem cell 
transplantation reduces regional wall stresses and infarct size and mitigates the 
adverse effects of LV remodeling as seen by a reduction in LV hypertrophy and 
LV dilatation and is associated with differential expression of genes relating to 
metabolism and apoptosis. 
 
We have also created a model of chronic hibernation in mini-pigs by placing a 
titanium c-shaped occluder device over the proximal LAD and described the 
longest follow up of experimental chronic hibernation in a pre-clinical large animal 
model. These studies utilized cardiac MRI to demonstrate the temporal changes 
in blood flow and regional function in hibernating myocardium to elucidate the 
exact timing of development of the phenomenon of hibernating myocardium in 
these animals. More importantly, we concluded that the myocardial energetic 
state as reflected by PCr/ATP ratio, is normal under baseline conditions up to 6 
months in hibernating myocardium despite a reduction in perfusion reserve and 
regional function. Furthermore, the decrease in PCr/ATP ratio with increased 
workload in hibernating myocardium is similar to normal myocardium. This is 
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probably related to an intrinsic down-regulation in the mitochondrial function 
which minimizes oxidative stress and leads to a balanced supply and demand at 
baseline and increased work load.  
 
Finally, we examined the effect of adenosine and K+ATP channel blockade on 
myocardial energetic in the failing heart. We demonstrate that adenosine 
receptor blockade has no effect on myocardial energetics in the failing heart 
despite an increase in myocardial blood flow. On the other hand, K+ATP channel 
blockade in the failing heart is associated with a significant decrease in the 
PCr/ATP ratio and ATP production rate via CK which is associated with a 
decrease in myocardial blood flow and tissue hypoxia. Thus, in failing hearts 
without coronary artery disease, the balance between myocardial ATP demands 
(or oxygen demands) and delivery are critically dependent on functioning KATP 
channels but not adenosine receptors.   
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